TW202146566A - Cured film-forming composition, alignment material, and phase difference material - Google Patents

Cured film-forming composition, alignment material, and phase difference material Download PDF

Info

Publication number
TW202146566A
TW202146566A TW110104541A TW110104541A TW202146566A TW 202146566 A TW202146566 A TW 202146566A TW 110104541 A TW110104541 A TW 110104541A TW 110104541 A TW110104541 A TW 110104541A TW 202146566 A TW202146566 A TW 202146566A
Authority
TW
Taiwan
Prior art keywords
group
component
cured film
mass
forming composition
Prior art date
Application number
TW110104541A
Other languages
Chinese (zh)
Inventor
井上翔太
伊藤潤
西村也
Original Assignee
日商日產化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學股份有限公司 filed Critical 日商日產化學股份有限公司
Publication of TW202146566A publication Critical patent/TW202146566A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • C08L101/02Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • G02F1/13363Birefringent elements, e.g. for optical compensation
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mathematical Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Liquid Crystal (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

To provide a cured film-forming composition that forms a cured film that exhibits an excellent adhesiveness for glass substrates and that exhibits excellent liquid crystal alignment properties and optical transparency when used as an alignment material and a layer of polymerizable liquid crystal is disposed thereon. A cured film-forming composition comprising (A) a polymer having a photoalignment group and a thermally crosslinkable group, (B) a crosslinking agent having a methylol group or alkoxymethyl group, and (C) an alkoxysilane having a thermally crosslinkable group different from the alkoxysilyl moiety. An alignment material characteristically obtained using the composition, and a phase difference material characteristically obtained using the composition.

Description

硬化膜形成組成物、配向材料及相位差材料Cured film forming composition, alignment material and retardation material

本發明係關於使液晶分子配向之光配向用液晶配向劑、配向材料及相位差材料。尤其是本發明係關於用以製作使用在圓偏光眼鏡方式之3D顯示器的經圖型化之相位差材料,或使用在作為有機EL顯示器的抗反射膜使用之圓偏光板的相位差材料有用之光配向用液晶配向劑、配向材料及相位差材料。The present invention relates to a liquid crystal alignment agent for photo-alignment, an alignment material and a retardation material for aligning liquid crystal molecules. In particular, the present invention relates to a patterned phase difference material for making a 3D display used in circularly polarized glasses, or a phase difference material used for a circularly polarizing plate used as an antireflection film of an organic EL display. Liquid crystal alignment agent for photo-alignment, alignment material and retardation material.

為圓偏光眼鏡方式之3D顯示器時,通常為於形成液晶面板等之圖像的顯示元件之上配置相位差材料。此相位差材料係已分別複數、規則性配置相位差特性不同之2種類的相位差區域,而構成了被圖型化之相位差材料。尚,以下,在本說明書,以配置這般的相位差特性不同之複數個相位差區域的方式,將被圖型化之相位差材料稱為圖型化相位差材料。In the case of a 3D display of the circularly polarized glasses type, a retardation material is usually arranged on a display element that forms an image of a liquid crystal panel or the like. In this retardation material, two types of retardation regions with different retardation characteristics are arranged in a complex number and regularly, and a patterned retardation material is formed. Hereinafter, in this specification, a patterned phase difference material is referred to as a patterned phase difference material so as to arrange a plurality of phase difference regions having different phase difference characteristics.

圖型化相位差材料,例如如專利文獻1所揭示,可藉由光學圖型化由聚合性液晶所構成之相位差材料製作。由聚合性液晶所構成之相位差材料的光學圖型化,係利用於液晶面板的配向材料形成已知的光配向技術。亦即,於基板上設置由光配向性的材料所構成之塗膜,並對此照射偏光方向不同之2種類的偏光。而且,作為形成液晶之配向控制方向不同之2種類的液晶配向區域的配向材料,而得到光配向膜。於此光配向膜之上塗佈包含聚合性液晶之溶液狀的相位差材料,而實現聚合性液晶的配向。然後,硬化經配向之聚合性液晶,形成圖型化相位差材料。A patterned retardation material, as disclosed in, for example, Patent Document 1, can be produced by optically patterning a retardation material composed of a polymerizable liquid crystal. The optical patterning of the retardation material composed of polymerizable liquid crystal is a known photo-alignment technique using the alignment material used in the liquid crystal panel. That is, a coating film made of a photo-alignment material is provided on the substrate, and two types of polarized light having different polarization directions are irradiated thereon. Furthermore, a photo-alignment film was obtained as an alignment material for forming two types of liquid crystal alignment regions in which the alignment control directions of the liquid crystal were different. A solution-like retardation material containing polymerizable liquid crystal is coated on the photo-alignment film to realize the alignment of the polymerizable liquid crystal. Then, the aligned polymerizable liquid crystal is cured to form a patterned retardation material.

有機EL顯示器之抗反射膜係藉由直線偏光板、1/4波長相位差板構成,將朝向圖像顯示面板的面板面之外來光藉由直線偏光板,變換成直線偏光,接著,藉由1/4波長相位差板變換成圓偏光。於此,藉由此圓偏光之外來光雖於圖像顯示面板的表面等進行反射,但於此反射時,逆轉偏光面的回轉方向。其結果,此反射光與到來時相反,由1/4波長相位差板,變換成藉由直線偏光板而被遮光之方向的直線偏光後,接著,藉由直線偏光板而被遮光,其結果,顯著抑制對外部之出射。The anti-reflection film of the organic EL display is composed of a linear polarizer and a 1/4 wavelength retardation plate, and the light from the outside of the panel surface facing the image display panel is converted into linear polarized light by the linear polarizer. The 1/4 wavelength retardation plate is converted into circularly polarized light. Here, although the external light is reflected on the surface of the image display panel or the like by the circularly polarized light, the rotation direction of the polarized plane is reversed during the reflection. As a result, the reflected light is converted into linearly polarized light in the direction blocked by the linear polarizer by the 1/4 wavelength retardation plate, opposite to when it arrived, and then blocked by the linear polarizer. , significantly inhibits the emission to the outside.

關於此1/4波長相位差板,專利文獻2中提案有藉由組合1/2波長板、1/4波長板,構成1/4波長相位差板,將此光學薄膜藉由逆分散特性構成之方法。為此方法時,在供於彩色圖像的顯示之廣泛波長頻帶,使用藉由正的分散特性之液晶材料,並藉由逆分散特性,可構成光學薄膜。Regarding this 1/4 wavelength retardation plate, Patent Document 2 proposes that a 1/4 wavelength retardation plate is formed by combining a 1/2 wavelength plate and a 1/4 wavelength plate, and this optical film is constituted by reverse dispersion characteristics method. In this method, an optical thin film can be formed by using a liquid crystal material with positive dispersion properties in a wide wavelength band for display of color images and with reverse dispersion properties.

又,近年來,作為可適用在此相位差層之液晶材料,提案有具備逆分散特性者(專利文獻3、4)。根據這般的逆分散特性之液晶材料,取代組合1/2波長板、1/4波長板,藉由2層之相位差層,構成1/4波長相位差板,將相位差層藉由單層構成,可確保逆分散特性,藉此,在廣泛之波長頻帶,將可確保所期望之相位差的光學薄膜藉由簡易的構成實現。In addition, in recent years, as a liquid crystal material applicable to this retardation layer, those having reverse dispersion properties have been proposed (Patent Documents 3 and 4). According to the liquid crystal material with such reverse dispersion characteristics, instead of combining the 1/2 wavelength plate and the 1/4 wavelength plate, a 1/4 wavelength retardation plate is formed by two retardation layers, and the retardation layer is formed by a single The layer structure can ensure the reverse dispersion characteristics, and thereby, an optical film that can ensure a desired retardation in a wide wavelength band can be realized with a simple structure.

為了使液晶配向而使用配向層。作為配向層的形成方法,例如已知有摩擦法或光配向法,光配向法沒有摩擦法的問題點即靜電或塵埃的發生,於可控制定量的配向處理的點為有用。An alignment layer is used to align the liquid crystal. As a method for forming an alignment layer, for example, a rubbing method and a photo-alignment method are known. The photo-alignment method does not have the problem of the rubbing method, ie, the generation of static electricity and dust, and is useful in that a quantitative alignment treatment can be controlled.

於使用光配向法之配向材料形成,作為可利用之光配向性的材料,已知有於側鏈具有肉桂醯基及查耳酮基等之光二聚化部位之丙烯酸樹脂或聚醯亞胺樹脂等。報告有此等之樹脂顯示藉由照射偏光UV,控制液晶的配向之性能(以下,亦稱為液晶配向性)(參照專利文獻5~專利文獻7)。In the formation of an alignment material using a photo-alignment method, acrylic resins or polyimide resins having photodimerization sites such as cinnamyl groups and chalcone groups in their side chains are known as materials with photo-alignment properties that can be used. Wait. It is reported that these resins exhibit the performance of controlling the alignment of liquid crystal by irradiating polarized light UV (hereinafter, also referred to as liquid crystal alignment) (refer to Patent Documents 5 to 7).

又,配向層中除了液晶配向能之外,尚要求耐溶劑性。例如,配向層在相位差材料的製造過程有被曝露在熱或溶劑的情況。配向層曝露在溶劑時,有顯著降低液晶配向能之虞。Moreover, in addition to the liquid crystal alignment energy, solvent resistance is also required in the alignment layer. For example, the alignment layer may be exposed to heat or solvent during the manufacturing process of the retardation material. When the alignment layer is exposed to a solvent, the alignment energy of the liquid crystal may be significantly reduced.

因此,例如專利文獻8中,為了得到經安定之液晶配向能,提案有含有具有藉由光交聯反應可能之構造與藉由熱進行交聯之構造的聚合物成分的液晶配向劑,及含有具有藉由光交聯反應可能之構造的聚合物成分與具有藉由熱進行交聯之構造的化合物的液晶配向劑。 [先前技術文獻] [專利文獻]Therefore, for example, in Patent Document 8, in order to obtain stabilized liquid crystal alignment energy, a liquid crystal alignment agent containing a polymer component having a structure capable of photocrosslinking reaction and a structure capable of being crosslinked by heat is proposed, and a liquid crystal alignment agent containing A liquid crystal aligning agent having a polymer component having a structure capable of photocrosslinking and a compound having a structure capable of being crosslinked by heat. [Prior Art Literature] [Patent Literature]

[專利文獻1] 日本特開2005-49865號公報 [專利文獻2] 日本特開平10-68816號公報 [專利文獻3] 美國專利第8119026號說明書 [專利文獻4] 日本特開2009-179563號公報 [專利文獻5] 日本專利第3611342號公報 [專利文獻6] 日本特開2009-058584號公報 [專利文獻7] 日本特表2001-517719號公報 [專利文獻8] 日本專利第4207430號公報[Patent Document 1] Japanese Patent Laid-Open No. 2005-49865 [Patent Document 2] Japanese Patent Application Laid-Open No. 10-68816 [Patent Document 3] Specification of US Patent No. 8119026 [Patent Document 4] Japanese Patent Laid-Open No. 2009-179563 [Patent Document 5] Japanese Patent No. 3611342 [Patent Document 6] Japanese Patent Laid-Open No. 2009-058584 [Patent Document 7] Japanese Patent Publication No. 2001-517719 [Patent Document 8] Japanese Patent No. 4207430

[發明欲解決之課題][The problem to be solved by the invention]

如以上,相位差材料係於配向材料的光配向膜之上,層合經硬化之聚合性液晶之層而構成。因此,可兼備優異之液晶配向性與耐溶劑性之配向材料的開發變必要。As described above, the retardation material is formed by laminating a layer of a cured polymerizable liquid crystal on the photo-alignment film of the alignment material. Therefore, it is necessary to develop an alignment material that can have both excellent liquid crystal alignment and solvent resistance.

然而,根據本發明者的研究,瞭解到於側鏈具有肉桂醯基或查耳酮基等之光二聚化部位之丙烯酸樹脂,適用在相位差材料的形成時,得不到充分之特性。尤其是於此等之樹脂照射偏光UV,形成配向材料,並使用該配向材料,為了製作由聚合性液晶所構成之相位差材料,大幅偏光UV曝光量成為必要。該偏光UV曝光量為了使通常之液晶面板用之液晶配向,較充分之偏光UV曝光量(例如為30mJ/cm2 左右)更加增多。However, according to the research of the present inventors, it was found that the acrylic resin having a photodimerization site such as a cinnamyl group or a chalcone group in its side chain does not have sufficient properties when applied to the formation of a retardation material. In particular, these resins are irradiated with polarized UV light to form an alignment material, and in order to produce a retardation material composed of a polymerizable liquid crystal by using the alignment material, a large amount of polarized light UV exposure is required. In order to align the liquid crystal for a normal liquid crystal panel, the amount of polarized UV exposure is more than a sufficient amount of polarized UV exposure (for example, about 30 mJ/cm 2 ).

作為增多偏光UV曝光量的理由,可列舉相位差材料形成時,與液晶面板用之液晶不同,係聚合性液晶以溶液的狀態使用,塗佈在配向材料之上。As a reason for increasing the amount of polarized UV exposure, when forming a retardation material, unlike liquid crystals for liquid crystal panels, polymerizable liquid crystals are used in a solution state and coated on an alignment material.

使用於側鏈具有肉桂醯基等之光二聚化部位之丙烯酸樹脂等,形成配向材料,欲使聚合性液晶配向時,在該丙烯酸樹脂等,進行藉由光二聚化反應之光交聯。而且,至表現對於聚合性液晶溶液之耐性為止,有必要進行大幅曝光量之偏光照射。為了使液晶面板之液晶配向,通常僅二聚化反應光配向性之配向材料的表面即可。惟,欲使用上述之丙烯酸樹脂等之以往材料,對配向材料表現溶劑耐性時,有必要反應至配向材料的內部為止,更多的曝光量變成必要。其結果,有以往材料的配向感度縮小至非常小的問題。An acrylic resin or the like having a photodimerization site such as a cinnamyl group in its side chain is used to form an alignment material, and when a polymerizable liquid crystal is to be aligned, the acrylic resin or the like is subjected to photocrosslinking by a photodimerization reaction. Furthermore, it is necessary to perform polarized light irradiation with a large exposure amount until the resistance to the polymerizable liquid crystal solution is expressed. In order to align the liquid crystal of the liquid crystal panel, usually only the surface of the alignment material with photo-alignment properties is dimerized. However, in order to use conventional materials such as the above-mentioned acrylic resins, when showing solvent resistance to the alignment material, it is necessary to react to the inside of the alignment material, and more exposure is required. As a result, there is a problem that the alignment sensitivity of the conventional material is reduced to a very small level.

又,於上述之以往材料之樹脂為了使這般的溶劑耐性表現,已知有添加交聯劑之技術。惟,進行藉由交聯劑之熱硬化反應後,瞭解到所形成之塗膜的內部中形成3次元構造,降低光反應性。亦即,導致大幅降低配向感度,即使於以往材料添加交聯劑使用,亦得不到成為所期望之效果。Moreover, in order to express such solvent resistance to the resin of the above-mentioned conventional material, the technique of adding a crosslinking agent is known. However, after the thermosetting reaction by the crosslinking agent was carried out, it was found that a 3-dimensional structure was formed in the inside of the formed coating film, and the photoreactivity was reduced. That is, the alignment sensitivity is greatly lowered, and even if a crosslinking agent is added to a conventional material, the desired effect cannot be obtained.

由以上,正尋求使配向材料的配向感度提昇,可減低偏光UV曝光量之光配向技術、與該配向材料的形成所使用之光配向用液晶配向劑。而且,正尋求可高效率提供相位差材料之技術。From the above, the photo-alignment technology that can improve the alignment sensitivity of the alignment material and reduce the UV exposure of polarized light, and the liquid crystal alignment agent for photo-alignment used in the formation of the alignment material are being sought. Furthermore, a technology that can provide a phase difference material with high efficiency is being sought.

又,以往之相位差材料雖藉由於薄膜上層合配向材料或液晶來製作,但藉由於顯示元件之玻璃基板上,製膜直接配向膜,從相位差材料排除1片份薄膜,正在嘗試成本減低與薄型化。這般的情況下,由於配向材料中與玻璃表面之充分的密著性成為必要,正尋求可兼備高液晶配向性與對玻璃基板之密著性的技術。In addition, although the conventional retardation material is produced by laminating an alignment material or liquid crystal on a thin film, by forming a direct alignment film on the glass substrate of the display element, a film is excluded from the retardation material, and an attempt is being made to reduce the cost. and thinning. In such a case, since sufficient adhesion to the glass surface is required in the alignment material, a technology that can achieve both high liquid crystal alignment and adhesion to a glass substrate is being sought.

本發明之目的係根據以上之發現或研究結果而完成者。亦即,本發明之目的係提供一種具有優異之耐溶劑性,並可以高感度使聚合性液晶配向,並且用以提供與玻璃基板的密著性優異之配向材料的光配向用液晶配向劑。The object of the present invention is accomplished based on the above findings or research results. That is, the object of the present invention is to provide a liquid crystal aligning agent for photo-alignment which has excellent solvent resistance, can align polymerizable liquid crystals with high sensitivity, and provides an alignment material excellent in adhesion to a glass substrate.

本發明之其他目的及優點從以下之記載即可清楚明白。 [用以解決課題之手段]Other objects and advantages of the present invention will be apparent from the description below. [means to solve the problem]

本發明者們為了達成上述目的,重複努力研究的結果,發現藉由選擇將(A)具有環氧基之聚合物與特定之肉桂酸衍生物的反應生成物、(B)具有羥甲基或烷氧基甲基之交聯劑,及(C)具有與烷氧基矽烷基部位不同之交聯性基的烷氧基矽烷作為基底之硬化膜形成材料,可形成具有優異之耐溶劑性,並可以高感度使聚合性液晶配向之硬化膜,而完成本發明。The present inventors, as a result of repeated efforts to achieve the above object, found that by selecting (A) a reaction product of a polymer having an epoxy group and a specific cinnamic acid derivative, (B) having a hydroxymethyl group or The crosslinking agent of alkoxymethyl group, and (C) alkoxysilane having a crosslinking group different from the alkoxysilyl group part as the hard film forming material of the base, can be formed with excellent solvent resistance, In addition, the present invention can be completed as a cured film capable of aligning polymerizable liquid crystals with high sensitivity.

亦即,本發明作為第1觀點,係關於一種硬化膜形成組成物,其係含有: (A)具有光配向性基及熱交聯性基之聚合物、 (B)具有羥甲基或烷氧基甲基之交聯劑,及 (C)具有與烷氧基矽烷基部位不同之熱交聯性基之烷氧基矽烷。 作為第2觀點,係關於如第1觀點所記載之硬化膜形成組成物,其係進一步含有(D)交聯觸媒。 作為第3觀點,係關於如第1觀點或第2觀點所記載之硬化膜形成組成物,其係含有(E)具有一個以上之自由基聚合性基,並具有選自羥基及N-烷氧基甲基中之基的化合物。 作為第4觀點,係關於如第1觀點至第3觀點中任一項所記載之硬化膜形成組成物,其係根據(A)成分100質量份,含有1質量份~500質量份之(B)成分。 作為第5觀點,係關於如第1觀點至第4觀點中任一項所記載之硬化膜形成組成物,其係相對於(A)成分及(B)成分之交聯劑的合計量之100質量份,含有0.001質量份~20質量份之(C)成分。 作為第6觀點,係關於如第2觀點至第5觀點中任一項所記載之硬化膜形成組成物,其係相對於(A)成分及(B)成分之交聯劑的合計量之100質量份,含有0.01質量份~20質量份之(D)成分。 作為第7觀點,係關於如第3觀點至第6觀點中任一項所記載之硬化膜形成組成物,其係相對於(A)成分及(B)成分之交聯劑的合計量之100質量份,含有1質量份~100質量份之(E)成分。 作為第8觀點,係關於一種硬化膜,其特徵為使如第1觀點至第7觀點中任一項所記載之硬化膜形成組成物硬化而獲得。 作為第9觀點,係關於一種配向材料,其特徵為使如第1觀點至第7觀點中任一項所記載之硬化膜形成組成物硬化而獲得。 作為第10觀點,係關於一種相位差材料,其特徵為使用如第1觀點至第7觀點中任一項所記載之硬化膜形成組成物所得之硬化膜而形成。 [發明效果]That is, the present invention relates to a cured film-forming composition containing: (A) a polymer having a photoalignment group and a thermally crosslinkable group, (B) a crosslinking agent having a methylol or alkoxymethyl group, and (C) The alkoxysilane which has a thermally crosslinkable group different from an alkoxysilyl group part. As a 2nd viewpoint, it is about the cured film formation composition as described in a 1st viewpoint which further contains (D) a crosslinking catalyst. As a 3rd viewpoint, it is about the cured film formation composition as described in a 1st viewpoint or a 2nd viewpoint which contains (E) has one or more radical polymerizable groups, and has a hydroxyl group and an N-alkoxy group selected from A compound containing the radical in the methyl group. As a 4th viewpoint, it is about the cured film forming composition described in any one of the 1st viewpoint to the 3rd viewpoint, which contains 1 mass part - 500 mass parts of (B) based on 100 mass parts of (A) components )Element. As a 5th viewpoint, it is about 100 of the total amount of the crosslinking agent with respect to (A) component and (B) component about the cured film forming composition as described in any one of the 1st viewpoint to the 4th viewpoint Part by mass, 0.001 parts by mass to 20 parts by mass of (C) component are contained. As a 6th viewpoint, it is about 100 of the total amount of the crosslinking agent with respect to (A) component and (B) component about the cured film forming composition as described in any one of the 2nd viewpoint to the 5th viewpoint Part by mass, 0.01 part by mass to 20 parts by mass of (D) component is contained. As a 7th viewpoint, it is about 100 of the total amount of the crosslinking agent with respect to (A) component and (B) component about the cured film forming composition as described in any one of the 3rd viewpoint to the 6th viewpoint Part by mass, 1 to 100 parts by mass of (E) component is contained. As a 8th viewpoint, it is about the cured film obtained by hardening the cured film-forming composition as described in any one of the 1st viewpoint to the 7th viewpoint. As a ninth viewpoint, it is about an alignment material obtained by hardening the cured film-forming composition described in any one of the first viewpoint to the seventh viewpoint. As a 10th viewpoint, it is about the retardation material characterized by using the cured film obtained from the cured film formation composition as described in any one of the 1st viewpoint to the 7th viewpoint, and it is formed. [Inventive effect]

根據本發明,可提供一種具有優異之耐溶劑性,並可以高感度使聚合性液晶配向,並且與玻璃基板的密著性優異之硬化膜、與適合在該形成之硬化膜形成組成物。 根據本發明,可提供一種液晶配向性與光透過性優異之配向材料,及高精度之光學圖型化為可能之相位差材料。According to the present invention, it is possible to provide a cured film which has excellent solvent resistance, can align polymerizable liquid crystals with high sensitivity, and is excellent in adhesion to a glass substrate, and a cured film-forming composition suitable for the formation thereon. According to the present invention, an alignment material excellent in liquid crystal alignment and light transmittance, and a retardation material capable of high-precision optical patterning can be provided.

<硬化膜形成組成物><Curing film forming composition>

本發明之硬化膜形成組成物,係含有(A)具有光配向性基及熱交聯性基之聚合物、(B)具有羥甲基或烷氧基甲基之交聯劑,及(C)具有與烷氧基矽烷基部位不同之熱交聯性基之烷氧基矽烷。本發明之硬化膜形成組成物除了上述(A)成分、(B)成分及(C)成分外,亦可進一步含有交聯觸媒作為(D)成分。進而作為(E)成分,可含有:具有一個以上之自由基聚合性基,並具有選自羥基及N-烷氧基甲基中之基的化合物。而且,在不損害本發明效果,可含有其他添加劑。 以下,說明各成分之詳細。The cured film-forming composition of the present invention contains (A) a polymer having a photoalignment group and a thermal crosslinking group, (B) a crosslinking agent having a methylol or alkoxymethyl group, and (C) ) An alkoxysilane having a thermally crosslinkable group different from the alkoxysilyl moiety. In addition to the said (A) component, (B) component, and (C) component, the cured film formation composition of this invention may further contain a crosslinking catalyst as (D) component. Furthermore, as (E) component, the compound which has one or more radically polymerizable groups and has a group selected from a hydroxyl group and an N-alkoxymethyl group can be contained. Furthermore, other additives may be contained without impairing the effect of the present invention. Hereinafter, the details of each component will be described.

<(A)成分> 在本發明之硬化膜形成組成物的(A)成分,係具有光配向性基及熱交聯性基之聚合物。亦即,(A)成分係對從本發明之硬化膜形成組成物所得之硬化膜賦予光配向性之成分,在本說明書,亦將(A)成分稱為光配向成分。<(A) Ingredient> The component (A) in the cured film forming composition of the present invention is a polymer having a photoalignment group and a thermally crosslinkable group. That is, (A) component is a component which provides photo-alignment property to the cured film obtained from the cured-film formation composition of this invention, and (A) component is also called a photo-alignment component in this specification.

本發明之硬化膜形成組成物所含有之(A)成分,其係具有光配向性基之聚合物,亦即,作為光配向性基,較佳為具有光二聚化或光異構化之構造部位的官能基之聚合物,尤其是至少具有光二聚化部位之丙烯酸共聚物。進而,除了光二聚化部位之外,期望為具有選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所構成之群組中之一個基(以下,包含此等之基亦稱為熱交聯部位)的丙烯酸共聚物。Component (A) contained in the cured film-forming composition of the present invention is a polymer having a photoalignment group, that is, as a photoalignment group, preferably, a structure having photodimerization or photoisomerization The polymer of the functional group of the site, especially the acrylic copolymer having at least a photodimerization site. Furthermore, in addition to the photodimerization site, it is desirable to have one group selected from the group consisting of a hydroxyl group, a carboxyl group, an amide group, an amino group, and an alkoxysilyl group (hereinafter, a group including these is also referred to as acrylic copolymers that are thermally cross-linked sites).

在本發明,所謂丙烯酸共聚物,係指聚合丙烯酸酯、甲基丙烯酸酯、苯乙烯等之具有不飽和雙鍵的單體所得之共聚物。In the present invention, the term "acrylic copolymer" refers to a copolymer obtained by polymerizing monomers having unsaturated double bonds such as acrylate, methacrylate, and styrene.

(A)成分之具有光二聚化部位及熱交聯部位之丙烯酸共聚物(以下,亦稱為特定共聚物),若為具有該構造之丙烯酸共聚物即可,針對構成丙烯酸共聚物之高分子的主鏈的骨架及側鏈的種類等,並未特別限定。The acrylic copolymer (hereinafter, also referred to as a specific copolymer) having a photodimerization site and a thermal crosslinking site of the component (A) may be an acrylic copolymer having such a structure. The skeleton of the main chain and the types of side chains are not particularly limited.

作為光二聚化部位,例如可列舉肉桂醯基、查耳酮基、香豆素基、蒽基等。此等當中,從於可見光區域之透明性的高度及光二聚化反應性的高度來看,較佳為肉桂醯基。作為更佳之肉桂醯基及包含肉桂醯基構造之取代基,可列舉下述式[1]或式[2]表示之構造。尚,在本說明書,即使針對在肉桂醯基之苯環為萘環的基,亦包含在「肉桂醯基」及「包含肉桂醯基構造之取代基」。As a photodimerization site|part, a cinnamyl group, a chalcone group, a coumarin group, an anthracenyl group, etc. are mentioned, for example. Among these, a cinnamonyl group is preferable from the viewpoint of the high transparency in the visible light region and the high photodimerization reactivity. As a more preferable cinnamyl group and a substituent containing a structure of a cinnamyl group, the structure represented by the following formula [1] or formula [2] can be mentioned. Furthermore, in this specification, even if the benzene ring of the cinnamyl group is a naphthalene ring, it is also included in the "cinnamyl group" and the "substituent containing a cinnamyl group structure".

Figure 02_image001
Figure 02_image001

上述式[1]中,X1 係表示氫原子、碳原子數1至18之烷基、苯基或聯苯基。此時,苯基及聯苯基可被鹵素原子及氰基之任一者取代。In the above formula [1], X 1 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a phenyl group or a biphenyl group. In this case, the phenyl group and the biphenyl group may be substituted with any one of a halogen atom and a cyano group.

上述式[2]中,X2 係表示氫原子、氰基、碳原子數1至18之烷基、苯基、聯苯基、環己基。此時,碳原子數1至18之烷基、苯基、聯苯基、環己基可透過選自共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵、胺基甲酸酯鍵、胺鍵、羰基或該等之組合中之1種或2種以上之鍵結,來鍵結複數種。In the above formula [2], X 2 represents a hydrogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cyclohexyl group. At this time, the alkyl group, phenyl group, biphenyl group, and cyclohexyl group having 1 to 18 carbon atoms can pass through a bond selected from the group consisting of covalent bond, ether bond, ester bond, amide bond, urea bond, urethane bond, The amine bond, the carbonyl group, or a combination of one or two or more of these bonds are used to bond a plurality of types.

上述式[1]及式[2]中,A係表示式[A1]、式[A2]、式[A3]、式[A4]、式[A5]及式[A6]之任一者。In the above-mentioned formula [1] and formula [2], A represents any one of formula [A1], formula [A2], formula [A3], formula [A4], formula [A5], and formula [A6].

上述式[A1]、式[A2]、式[A3]、式[A4]、式[A5]及式[A6]中,R31 、R32 、R33 、R34 、R35 、R36 、R37 及R38 分別獨立表示氫原子、碳原子數1至4之烷基、碳原子數1至4之烷氧基、鹵素原子、三氟甲基或氰基。In the above formula [A1], formula [A2], formula [A3], formula [A4], formula [A5] and formula [A6], R 31 , R 32 , R 33 , R 34 , R 35 , R 36 , R 37 and R 38 each independently represent a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a trifluoromethyl group or a cyano group.

熱交聯部位係藉由加熱與(B)成分之交聯劑鍵結之部位,作為其具體例,可列舉羥基、羧基、醯胺基、胺基、烷氧基矽烷基等。The thermal crosslinking site is a site bonded to the crosslinking agent of the component (B) by heating, and specific examples thereof include a hydroxyl group, a carboxyl group, an amide group, an amino group, and an alkoxysilyl group.

(A)成分之丙烯酸共聚物較佳為重量平均分子量為3,000至200,000。重量平均分子量超過200,000為過大者時,有降低對於溶劑之溶解性,並降低操作性的情況,另一方面,重量平均分子量未滿3,000為過小者時,有於熱硬化時成為硬化不足,降低溶劑耐性或是降低耐熱性的情況。The acrylic copolymer of the component (A) preferably has a weight average molecular weight of 3,000 to 200,000. If the weight-average molecular weight exceeds 200,000 and is too large, the solubility to the solvent may decrease and the handleability may be lowered. On the other hand, if the weight-average molecular weight is less than 3,000, if the weight-average molecular weight is too small, the curing is insufficient during thermal curing, and the decrease Solvent resistance or reduced heat resistance.

(A)成分之具有光二聚化部位及熱交聯部位之丙烯酸共聚物的合成方法,係共聚合具有光二聚化部位之單體、與具有熱交聯部位之單體的方法為簡便。The method for synthesizing the acrylic copolymer having a photodimerization site and a thermal crosslinking site of the component (A) is a simple method of copolymerizing a monomer having a photodimerization site and a monomer having a thermal crosslinking site.

作為具有光二聚化部位之單體,例如可列舉具有肉桂醯基、查耳酮基、香豆素基、蒽基等之單體。此等當中,從於可見光區域之透明性的高度及光二聚化反應性的高度來看,特佳為具有肉桂醯基之單體。As a monomer which has a photodimerization site|part, the monomer which has a cinnamyl group, a chalcone group, a coumarin group, an anthracene group, etc. is mentioned, for example. Among these, a monomer having a cinnamyl group is particularly preferred from the viewpoint of high transparency in the visible light region and high photodimerization reactivity.

其中,更佳為具有上述式[1]或式[2]表示之構造的肉桂醯基及包含肉桂醯基構造的取代基之單體。列舉這般的單體的具體例時,為下述式[3]或式[4]表示之單體。Among them, more preferred are a cinnamyl group having a structure represented by the above formula [1] or formula [2] and a monomer containing a substituent having a cinnamyl group structure. When a specific example of such a monomer is given, it is a monomer represented by following formula [3] or formula [4].

Figure 02_image003
Figure 02_image003

上述式[3]中,X1 係表示氫原子、碳原子數1至18之烷基、苯基或聯苯基。此時,苯基及聯苯基可被鹵素原子及氰基之任一者取代。 L1 及L2 分別獨立表示共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵或胺基甲酸酯鍵。In the above formula [3], X 1 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a phenyl group or a biphenyl group. In this case, the phenyl group and the biphenyl group may be substituted with any one of a halogen atom and a cyano group. L 1 and L 2 each independently represent a covalent bond, an ether bond, an ester bond, an amide bond, a urea bond, or a urethane bond.

上述式[4]中,X2 係表示氫原子、氰基、碳原子數1至18之烷基、苯基、聯苯基、環己基。此時,碳原子數1至18之烷基、苯基、聯苯基、環己基可透過共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵鍵結。In the above formula [4], X 2 represents a hydrogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cyclohexyl group. In this case, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, and a cyclohexyl group can be bonded via a covalent bond, an ether bond, an ester bond, an amide bond, or a urea bond.

上述式[3]及式[4]中,X3 及X5 分別獨立表示單鍵、碳原子數1至20之伸烷基、2價之芳香族環、2價之脂肪族環。於此碳原子數1至20之伸烷基可為分枝狀,亦可為直鏈狀。In the above formulas [3] and [4], X 3 and X 5 each independently represent a single bond, an alkylene group having 1 to 20 carbon atoms, a divalent aromatic ring, and a divalent aliphatic ring. The alkylene group having 1 to 20 carbon atoms may be branched or linear.

上述式[3]及式[4]中,X4 係表示聚合性基。作為此聚合性基的具體例,例如可列舉丙烯醯基、甲基丙烯醯基、苯乙烯基、馬來醯亞胺基、丙烯醯胺基、甲基丙烯醯胺基等。In the above formula [3] and formula [4], X 4 represents a polymerizable group. As a specific example of this polymerizable group, an acrylyl group, a methacrylamide group, a styryl group, a maleimide group, an acrylamide group, a methacrylamido group, etc. are mentioned, for example.

上述式[3]及式[4]中,A與前述相同係表示式[A1]、式[A2]、式[A3]、式[A4]、式[A5]及式[A6]之任一者。In the above formulas [3] and [4], A is the same as that described above and represents any one of formula [A1], formula [A2], formula [A3], formula [A4], formula [A5] and formula [A6] By.

作為具有熱交聯部位之單體,例如可列舉2-羥基乙基丙烯酸酯、2-羥基乙基甲基丙烯酸酯、2-羥基丙基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、4-羥基丁基丙烯酸酯、4-羥基丁基甲基丙烯酸酯、2,3-二羥基丙基丙烯酸酯、2,3-二羥基丙基甲基丙烯酸酯、二乙二醇單丙烯酸酯、二乙二醇單甲基丙烯酸酯、己內酯2-(丙烯醯基氧基)乙基酯、己內酯2-(甲基丙烯醯基氧基)乙基酯、聚(乙二醇)乙基醚丙烯酸酯、聚(乙二醇)乙基醚甲基丙烯酸酯、5-丙烯醯基氧基-6-羥基降莰烯-2-羧酸基(Carboxylic)-6-內酯、5-甲基丙烯醯基氧基-6-羥基降莰烯-2-羧酸基(Carboxylic)-6-內酯等之具有羥基之單體;丙烯酸、甲基丙烯酸、巴豆酸、單-(2-(丙烯醯基氧基)乙基)鄰苯二甲酸酯、單-(2-(甲基丙烯醯基氧基)乙基)鄰苯二甲酸酯、N-(羧基苯基)馬來醯亞胺、N-(羧基苯基)甲基丙烯醯胺、N-(羧基苯基)丙烯醯胺等之具有羧基之單體;羥基苯乙烯、N-(羥基苯基)甲基丙烯醯胺、N-(羥基苯基)丙烯醯胺、N-(羥基苯基)馬來醯亞胺、N-(羥基苯基)馬來醯亞胺等之具有酚性羥基之單體;丙烯醯胺、甲基丙烯醯胺等之具有醯胺基之單體;甲基丙烯醯基氧基丙基三甲氧基矽烷、甲基丙烯醯基氧基丙基三乙氧基矽烷、丙烯醯基氧基丙基三甲氧基矽烷、丙烯醯基氧基丙基三乙氧基矽烷等之具有烷氧基矽烷基之單體等。Examples of the monomer having a thermally crosslinked site include 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, 2-hydroxypropyl methacrylate, 4-hydroxypropyl methacrylate, -Hydroxybutyl acrylate, 4-hydroxybutyl methacrylate, 2,3-dihydroxypropyl acrylate, 2,3-dihydroxypropyl methacrylate, diethylene glycol monoacrylate, diethylene glycol Alcohol monomethacrylate, caprolactone 2-(acryloyloxy)ethyl ester, caprolactone 2-(methacryloyloxy)ethyl ester, poly(ethylene glycol) ethyl ether Acrylate, poly(ethylene glycol) ethyl ether methacrylate, 5-acryloyloxy-6-hydroxynorbornene-2-carboxylic-6-lactone, 5-methyl Acryloyloxy-6-hydroxynorbornene-2-carboxylic acid group (Carboxylic)-6-lactone and other monomers with hydroxyl groups; acrylic acid, methacrylic acid, crotonic acid, mono-(2-(propylene) Acrylooxy)ethyl)phthalate, mono-(2-(methacryloyloxy)ethyl)phthalate, N-(carboxyphenyl)maleimide Amine, N-(carboxyphenyl)methacrylamide, N-(carboxyphenyl)acrylamide and other monomers with carboxyl groups; hydroxystyrene, N-(hydroxyphenyl)methacrylamide, Monomers with phenolic hydroxyl groups such as N-(hydroxyphenyl)acrylamide, N-(hydroxyphenyl)maleimide, N-(hydroxyphenyl)maleimide, etc.; acrylamide, Monomers with amide groups such as methacrylamido; methacryloyloxypropyltrimethoxysilane, methacryloyloxypropyltriethoxysilane, acryloyloxypropyl Monomers with alkoxysilyl groups such as acrylotrimethoxysilane, acryloxypropyltriethoxysilane, etc.

用以得到特定共聚物而使用之具有光二聚化部位之單體及具有熱交聯部位之單體的使用量,根據用以得到特定共聚物而使用之全單體的合計量,具有光二聚化部位之單體為40質量%~95質量%,較佳為具有熱交聯部位之單體為5質量%~60質量%。藉由將具有光二聚化部位之單體含量定為40質量%以上,可賦予高感度且良好之液晶配向性。另一方面,藉由定為95質量%以下,可賦予充分之熱硬化性,並可維持高感度且良好之液晶配向性。The amount of the monomer having a photodimerization site and the monomer having a thermal crosslinking site used to obtain the specific copolymer is based on the total amount of all monomers used to obtain the specific copolymer. The content of the monomer of the chemical moiety is 40% by mass to 95% by mass, and the content of the monomer having a thermal crosslinking site is preferably 5% by mass to 60% by mass. By setting the content of the monomer having a photodimerization site to 40% by mass or more, high sensitivity and favorable liquid crystal alignment can be imparted. On the other hand, by setting it as 95 mass % or less, sufficient thermosetting property can be provided, and high sensitivity and favorable liquid crystal orientation can be maintained.

又,在本發明之硬化膜形成組成物,得到特定共聚物時,可併用具有光二聚化部位及熱交聯部位(以下,亦將此等稱為特定官能基)之單體與可共聚合之單體(以下亦稱為具有非反應性官能基之單體)。Moreover, when a specific copolymer is obtained from the cured film-forming composition of the present invention, a monomer having a photodimerization site and a thermal crosslinking site (hereinafter, these are also referred to as specific functional groups) can be used together with a copolymerizable monomer. (hereinafter also referred to as monomers with non-reactive functional groups).

作為這般的單體的具體例,可列舉丙烯酸酯化合物、甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯醯胺化合物、丙烯腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等。 以下,雖列舉上述單體的具體例,但本發明並非被限定於此等者。Specific examples of such monomers include acrylate compounds, methacrylate compounds, maleimide compounds, acrylamide compounds, acrylonitrile, maleic anhydride, styrene compounds, vinyl compounds, and the like. Hereinafter, although specific examples of the above-mentioned monomers are given, the present invention is not limited to these.

作為上述之丙烯酸酯化合物,例如可列舉甲基丙烯酸酯、乙基丙烯酸酯、異丙基丙烯酸酯、苄基丙烯酸酯、萘基丙烯酸酯、蒽基丙烯酸酯、蒽基甲基丙烯酸酯、苯基丙烯酸酯、縮水甘油基丙烯酸酯、2,2,2-三氟乙基丙烯酸酯、tert-丁基丙烯酸酯、環己基丙烯酸酯、異莰基丙烯酸酯、2-甲氧基乙基丙烯酸酯、甲氧基三乙二醇丙烯酸酯、2-乙氧基乙基丙烯酸酯、四氫糠基丙烯酸酯、3-甲氧基丁基丙烯酸酯、2-甲基-2-金剛烷基丙烯酸酯、2-丙基-2-金剛烷基丙烯酸酯、8-甲基-8-三環癸基丙烯酸酯,及8-乙基-8-三環癸基丙烯酸酯等。Examples of the above-mentioned acrylate compound include methacrylate, ethacrylate, isopropyl acrylate, benzyl acrylate, naphthyl acrylate, anthracenyl acrylate, anthracenyl methacrylate, phenyl Acrylates, glycidyl acrylate, 2,2,2-trifluoroethyl acrylate, tert-butyl acrylate, cyclohexyl acrylate, isobornyl acrylate, 2-methoxyethyl acrylate, Methoxytriethylene glycol acrylate, 2-ethoxyethyl acrylate, tetrahydrofurfuryl acrylate, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2-adamantyl acrylate, 8-methyl-8-tricyclodecyl acrylate, and 8-ethyl-8-tricyclodecyl acrylate, etc.

作為上述之甲基丙烯酸酯化合物,例如可列舉甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、異丙基甲基丙烯酸酯、苄基甲基丙烯酸酯、萘基甲基丙烯酸酯、蒽基甲基丙烯酸酯、蒽基甲基甲基丙烯酸酯、苯基甲基丙烯酸酯、縮水甘油基甲基丙烯酸酯、2,2,2-三氟乙基甲基丙烯酸酯、tert-丁基甲基丙烯酸酯、環己基甲基丙烯酸酯、異莰基甲基丙烯酸酯、2-甲氧基乙基甲基丙烯酸酯、甲氧基三乙二醇甲基丙烯酸酯、2-乙氧基乙基甲基丙烯酸酯、四氫糠基甲基丙烯酸酯、3-甲氧基丁基甲基丙烯酸酯、2-甲基-2-金剛烷基甲基丙烯酸酯、γ-丁內酯甲基丙烯酸酯、2-丙基-2-金剛烷基甲基丙烯酸酯、8-甲基-8-三環癸基甲基丙烯酸酯,及8-乙基-8-三環癸基甲基丙烯酸酯等。Examples of the above-mentioned methacrylate compound include methmethacrylate, ethyl methacrylate, isopropyl methacrylate, benzyl methacrylate, naphthyl methacrylate, anthracenyl methacrylate, anthracenyl methacrylate, phenyl methacrylate, glycidyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate , cyclohexyl methacrylate, isobornyl methacrylate, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate ester, tetrahydrofurfuryl methacrylate, 3-methoxybutyl methacrylate, 2-methyl-2-adamantyl methacrylate, gamma-butyrolactone methacrylate, 2-propyl -2-adamantyl methacrylate, 8-methyl-8-tricyclodecyl methacrylate, and 8-ethyl-8-tricyclodecyl methacrylate, etc.

作為上述之乙烯基化合物,例如可列舉甲基乙烯基醚、苄基乙烯基醚、乙烯基萘、乙烯基咔唑、烯丙基縮水甘油基醚、3-乙烯基-7-氧雜聯環[4.1.0]庚烷、1,2-環氧基-5-己烯及1,7-辛二烯單環氧化物等。Examples of the above vinyl compound include methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl carbazole, allyl glycidyl ether, 3-vinyl-7-oxabicycle [4.1.0] Heptane, 1,2-epoxy-5-hexene, 1,7-octadiene monoepoxide, and the like.

作為上述之苯乙烯化合物,例如可列舉苯乙烯、甲基苯乙烯、氯苯乙烯及溴苯乙烯等。As said styrene compound, styrene, methylstyrene, chlorostyrene, bromostyrene, etc. are mentioned, for example.

作為上述之馬來醯亞胺化合物,例如可列舉馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺及N-環己基馬來醯亞胺等。As said maleimide compound, maleimide, N-methylmaleimide, N-phenylmaleimide, N-cyclohexylmaleimide, etc. are mentioned, for example.

得到本發明之硬化膜形成組成物所使用之特定共聚物之方法雖並未特別限定,但例如在使具有特定官能基之單體(具有光二聚化部位之單體及具有熱交聯部位之單體)、視期望具有非反應性官能基之單體及聚合起始劑等共存之溶劑中,於50℃~110℃的溫度下進行聚合反應而獲得。此時,所使用之溶劑若為溶解具有特定官能基之單體、視期望而使用之具有非反應性官能基之單體及聚合起始劑等者,則並未特別限定。作為具體例,可列舉後述之溶劑所記載之溶劑。Although the method of obtaining the specific copolymer used in the cured film forming composition of the present invention is not particularly limited, for example, a monomer having a specific functional group (a monomer having a photodimerization site and a monomer having a thermal crosslinking site) is obtained. Monomer), a monomer having a non-reactive functional group as desired, and a solvent in which a polymerization initiator and the like coexist, and are obtained by carrying out a polymerization reaction at a temperature of 50°C to 110°C. At this time, the solvent to be used is not particularly limited as long as it dissolves a monomer having a specific functional group, a monomer having a non-reactive functional group, a polymerization initiator, and the like are used as desired. As a specific example, the solvent described in the solvent mentioned later is mentioned.

如此進行所得之特定共聚物通常為溶解在溶劑之溶液的狀態,在本發明可直接作為(A)成分之溶液使用。The specific copolymer obtained in this way is usually in the state of being dissolved in a solution of a solvent, and can be used directly as a solution of the component (A) in the present invention.

又,藉由將如上述進行所得之特定共聚物的溶液於二乙基醚或水等之攪拌下投入,使其再沉澱,過濾・洗淨經生成之沉澱物後,於常壓或減壓下進行常溫或者加熱乾燥,可成為特定共聚物的粉體。藉由這般的操作,可去除與特定共聚物共存之聚合起始劑或未反應單體,其結果,得到經純化之特定共聚物的粉體。無法以一度的操作充分純化時,將所得之粉體再溶解於溶劑,重複進行上述之操作即可。In addition, the solution of the specific copolymer obtained as described above is poured into diethyl ether, water, etc. with stirring to reprecipitate, and after filtering and washing the generated precipitate, the solution is placed under normal pressure or reduced pressure. It can be dried at room temperature or by heating to obtain a powder of a specific copolymer. By such an operation, the polymerization initiator or unreacted monomer coexisting with the specific copolymer can be removed, and as a result, a purified powder of the specific copolymer can be obtained. When sufficient purification cannot be performed in one operation, the obtained powder may be redissolved in a solvent, and the above operation may be repeated.

在本發明之硬化膜形成組成物,作為(A)成分,可直接使用上述特定共聚物的粉體,或者可將該粉體例如再溶解於後述之溶劑,作為溶液的狀態使用。In the cured film formation composition of this invention, the powder of the said specific copolymer can be used as it is as (A) component, or this powder can be redissolved in the solvent mentioned later, for example, and can be used as the state of a solution.

又,作為(A)成分,亦可使用於側鏈具有環氧基之聚合物,使肉桂酸衍生物進行反應所得之聚合物。Moreover, as (A) component, the polymer obtained by making a cinnamic-acid derivative react in the polymer which has an epoxy group in a side chain can also be used.

於側鏈具有環氧基之聚合物,例如可為具有環氧基之聚合性不飽和化合物的聚合物,或具有環氧基之聚合性不飽和化合物與其他聚合性不飽和化合物的共聚物。The polymer having an epoxy group in a side chain may be, for example, a polymer of a polymerizable unsaturated compound having an epoxy group, or a copolymer of a polymerizable unsaturated compound having an epoxy group and another polymerizable unsaturated compound.

作為具有環氧基之聚合性不飽和化合物的具體例,例如可列舉丙烯酸縮水甘油酯、甲基丙烯酸縮水甘油酯、α-乙基丙烯酸縮水甘油酯、α-n-丙基丙烯酸縮水甘油酯、α-n-丁基丙烯酸縮水甘油酯、丙烯酸-3,4-環氧基丁酯、甲基丙烯酸-3,4-環氧基丁酯、丙烯酸-6,7-環氧基庚酯、甲基丙烯酸-6,7-環氧基庚酯、α-乙基丙烯酸-6,7-環氧基庚酯、o-乙烯基苄基縮水甘油基醚、m-乙烯基苄基縮水甘油基醚、p-乙烯基苄基縮水甘油基醚等。Specific examples of the polymerizable unsaturated compound having an epoxy group include glycidyl acrylate, glycidyl methacrylate, α-ethyl glycidyl acrylate, α-n-propyl glycidyl acrylate, α-n-Butyl glycidyl acrylate, 3,4-epoxybutyl acrylate, 3,4-epoxybutyl methacrylate, 6,7-epoxyheptyl acrylate, methacrylate Ethyl acrylate-6,7-epoxyheptyl, α-ethylacrylate-6,7-epoxyheptyl, o-vinylbenzyl glycidyl ether, m-vinylbenzyl glycidyl ether , p-vinylbenzyl glycidyl ether, etc.

作為其他聚合性不飽和化合物,可列舉(甲基)丙烯酸烷基酯、(甲基)丙烯酸環狀烷基酯、甲基丙烯酸芳基酯、丙烯酸芳基酯、不飽和二羧酸二酯、聯環不飽和化合物類、馬來醯亞胺化合物類、不飽和芳香族化合物、共軛二烯系化合物、不飽和單羧酸、不飽和二羧酸、不飽和二羧酸酐、此等以外之聚合性不飽和化合物。Examples of other polymerizable unsaturated compounds include alkyl (meth)acrylate, cyclic alkyl (meth)acrylate, aryl methacrylate, aryl acrylate, unsaturated dicarboxylic acid diester, Bicyclic unsaturated compounds, maleimide compounds, unsaturated aromatic compounds, conjugated diene compounds, unsaturated monocarboxylic acids, unsaturated dicarboxylic acids, unsaturated dicarboxylic anhydrides, and others Polymerizable unsaturated compound.

作為此等之具體例,分別作為甲基丙烯酸烷基酯,例如可列舉羥基甲基甲基丙烯酸酯、2-羥基乙基甲基丙烯酸酯、3-羥基丙基甲基丙烯酸酯、4-羥基丁基甲基丙烯酸酯、二乙二醇單甲基丙烯酸酯、2,3-二羥基丙基甲基丙烯酸酯、2-甲基丙烯醯氧基乙基醣苷、4-羥基苯基甲基丙烯酸酯、甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、n-丁基甲基丙烯酸酯、sec-丁基甲基丙烯酸酯、2-乙基己基甲基丙烯酸酯、異癸基甲基丙烯酸酯、n-月桂基甲基丙烯酸酯、十三烷基甲基丙烯酸酯、n-硬脂基甲基丙烯酸酯等;作為丙烯酸烷基酯,例如可列舉甲基丙烯酸酯、異丙基丙烯酸酯等;作為甲基丙烯酸環狀烷基酯,例如可列舉環己基甲基丙烯酸酯、2-甲基環己基甲基丙烯酸酯、三環[5.2.1.02,6 ]癸烷-8-基甲基丙烯酸酯、三環[5.2.1.02,6 ]癸烷-8-基氧基乙基甲基丙烯酸酯、異莰基甲基丙烯酸酯、膽甾烷基(cholestanyl)甲基丙烯酸酯等;作為丙烯酸環狀烷基酯,例如可列舉環己基丙烯酸酯、2-甲基環己基丙烯酸酯、三環[5.2.1.02,6 ]癸烷-8-基丙烯酸酯、三環[5.2.1.02,6 ]癸烷-8-基氧基乙基丙烯酸酯、異莰基丙烯酸酯、膽甾烷基(cholestanyl)丙烯酸酯等;作為甲基丙烯酸芳基酯,可列舉苯基甲基丙烯酸酯、苄基甲基丙烯酸酯等;作為丙烯酸芳基酯,例如可列舉苯基丙烯酸酯、苄基丙烯酸酯等;作為不飽和二羧酸二酯,例如可列舉馬來酸二乙酯、富馬酸二乙酯、衣康酸二乙酯等;As specific examples of these, the alkyl methacrylates include, for example, hydroxymethyl methacrylate, 2-hydroxyethyl methacrylate, 3-hydroxypropyl methacrylate, and 4-hydroxyl methacrylate. Butyl methacrylate, diethylene glycol monomethacrylate, 2,3-dihydroxypropyl methacrylate, 2-methacryloyloxyethyl glycoside, 4-hydroxyphenyl methacrylate, methmethacrylate, ethyl methacrylate, n-butyl methacrylate, sec-butyl methacrylate, 2-ethylhexyl methacrylate, isodecyl methacrylate, n-lauryl Methacrylate, tridecyl methacrylate, n-stearyl methacrylate, etc.; as alkyl acrylate, for example, methacrylate, isopropyl acrylate, etc.; as methacrylic acid Cyclic alkyl esters include, for example, cyclohexyl methacrylate, 2-methylcyclohexyl methacrylate, tricyclo[5.2.1.0 2,6 ]decane-8-yl methacrylate, tricyclic [5.2.1.0 2,6 ] Decan-8-yloxyethyl methacrylate, isobornyl methacrylate, cholestanyl methacrylate, etc.; as acrylic cyclic alkyl Examples of esters include cyclohexyl acrylate, 2-methylcyclohexyl acrylate, tricyclo[5.2.1.0 2,6 ]decane-8-yl acrylate, tricyclo[5.2.1.0 2,6 ]decane -8-yloxyethyl acrylate, isocamphenyl acrylate, cholestanyl acrylate, etc.; aryl methacrylate, phenyl methacrylate, benzyl methacrylate, etc. acrylic acid aryl ester, for example, phenyl acrylate, benzyl acrylate, etc.; unsaturated dicarboxylic acid diester, for example, diethyl maleate, diethyl fumarate, Diethylconate, etc.;

作為聯環不飽和化合物類,例如可列舉聯環[2.2.1]庚-2-烯、5-甲基聯環[2.2.1]庚-2-烯、5-乙基聯環[2.2.1]庚-2-烯、5-甲氧基聯環[2.2.1]庚-2-烯、5-乙氧基聯環[2.2.1]庚-2-烯、5,6-二甲氧基聯環[2.2.1]庚-2-烯、5,6-二乙氧基聯環[2.2.1]庚-2-烯、5-(2’-羥基乙基)聯環[2.2.1]庚-2-烯、5,6-二羥基聯環[2.2.1]庚-2-烯、5,6-二(羥基甲基)聯環[2.2.1]庚-2-烯、5,6-二(2’-羥基乙基)聯環[2.2.1]庚-2-烯、5-羥基-5-甲基聯環[2.2.1]庚-2-烯、5-羥基-5-乙基聯環[2.2.1]庚-2-烯、5-羥基甲基-5-甲基聯環[2.2.1]庚-2-烯等;作為馬來醯亞胺化合物類,例如可列舉苯基馬來醯亞胺、環己基馬來醯亞胺、苄基馬來醯亞胺、N-琥珀醯亞胺基-3-馬來醯亞胺苯甲酸鹽、N-琥珀醯亞胺基-4-馬來醯亞胺丁酸酯、N-琥珀醯亞胺基-6-馬來醯亞胺己酸酯、N-琥珀醯亞胺基-3-馬來醯亞胺丙酸酯、N-(9-吖啶基)馬來醯亞胺等;作為不飽和芳香族化合物,例如可列舉苯乙烯、α-甲基苯乙烯、m-甲基苯乙烯、p-甲基苯乙烯、乙烯基甲苯、p-甲氧基苯乙烯等;作為共軛二烯系化合物,可列舉1,3-丁二烯、異戊二烯、2,3-二甲基-1,3-丁二烯等;作為不飽和單羧酸,例如可列舉丙烯酸、甲基丙烯酸、巴豆酸等;作為不飽和二羧酸,可列舉馬來酸、富馬酸、檸康酸、中康酸、衣康酸等;作為不飽和二羧酸酐,可列舉上述不飽和二羧酸之各酐;作為上述以外之聚合性不飽和化合物,例如可列舉丙烯腈、甲基丙烯腈、氯乙烯、偏二氯乙烯、丙烯醯胺、甲基丙烯醯胺、乙酸乙烯酯等。Examples of bicyclic unsaturated compounds include bicyclo[2.2.1]hept-2-ene, 5-methylbicyclo[2.2.1]hept-2-ene, and 5-ethylbicyclo[2.2. 1] Hept-2-ene, 5-methoxybicyclo[2.2.1]hept-2-ene, 5-ethoxybicyclo[2.2.1]hept-2-ene, 5,6-dimethyl Oxybicyclo[2.2.1]hept-2-ene, 5,6-diethoxybicyclo[2.2.1]hept-2-ene, 5-(2'-hydroxyethyl)bicyclo[2.2 .1]hept-2-ene, 5,6-dihydroxybicyclo[2.2.1]hept-2-ene, 5,6-bis(hydroxymethyl)bicyclo[2.2.1]hept-2-ene , 5,6-bis(2'-hydroxyethyl)bicyclo[2.2.1]hept-2-ene, 5-hydroxy-5-methylbicyclo[2.2.1]hept-2-ene, 5- Hydroxy-5-ethylbicyclo[2.2.1]hept-2-ene, 5-hydroxymethyl-5-methylbicyclo[2.2.1]hept-2-ene, etc.; as maleimide compounds such as phenylmaleimide, cyclohexylmaleimide, benzylmaleimide, N-succinimidyl-3-maleimide benzoate, N- -Succinimidyl-4-maleimide butyrate, N-succinimidyl-6-maleimide caproate, N-succinimidyl-3-maleimide iminopropionate, N-(9-acridinyl)maleimide, etc.; as unsaturated aromatic compounds, for example, styrene, α-methylstyrene, m-methylstyrene, p -Methylstyrene, vinyltoluene, p-methoxystyrene, etc.; as conjugated diene compounds, 1,3-butadiene, isoprene, 2,3-dimethyl- 1,3-butadiene, etc.; as unsaturated monocarboxylic acid, for example, acrylic acid, methacrylic acid, crotonic acid, etc.; as unsaturated dicarboxylic acid, maleic acid, fumaric acid, citraconic acid, Mesaconic acid, itaconic acid, etc.; Examples of unsaturated dicarboxylic acid anhydrides include the anhydrides of the above-mentioned unsaturated dicarboxylic acids; Examples of polymerizable unsaturated compounds other than the above include acrylonitrile, methacrylonitrile, chlorine Ethylene, vinylidene chloride, acrylamide, methacrylamide, vinyl acetate, etc.

在具有環氧基之聚合物的具有環氧基之聚合性不飽和化合物的共聚合比例,較佳為30重量%以上,更佳為50重量%以上。The copolymerization ratio of the polymerizable unsaturated compound having an epoxy group in the polymer having an epoxy group is preferably 30% by weight or more, more preferably 50% by weight or more.

具有環氧基之聚合物的合成,較佳為可藉由在溶媒中、適當之聚合起始劑的存在下之公知的自由基聚合法進行。The synthesis of the polymer having an epoxy group can preferably be carried out by a known radical polymerization method in a solvent in the presence of a suitable polymerization initiator.

作為於側鏈具有環氧基之聚合物,可使用市售品。作為該市售品,例如可列舉EHPE3150、EHPE3150CE(以上為Daicel化學工業(股)製)、UG-4010、UG-4035、UG-4040、UG-4070(以上為東亞合成(股)製ALUFON系列)、ECN-1299(旭化成(股)製)、DEN431、DEN438(以上為陶氏化學公司製)、jER-152(日本環氧樹脂(股)製)、EPICLON N-660、N-665、N-670、N-673、N-695、N-740、N-770、N-775(以上為大日本油墨化學工業(股)製)、EOCN-1020、EOCN-102S、EOCN-104S(以上為日本化藥(股)製)等。As a polymer which has an epoxy group in a side chain, a commercial item can be used. Examples of such commercially available products include EHPE3150, EHPE3150CE (the above are manufactured by Daicel Chemical Industry Co., Ltd.), UG-4010, UG-4035, UG-4040, and UG-4070 (the above are ALUFON series manufactured by Toagosei Co., Ltd.) ), ECN-1299 (manufactured by Asahi Kasei Co., Ltd.), DEN431, DEN438 (manufactured by The Dow Chemical Co., Ltd.), jER-152 (manufactured by Japan Epoxy Resin Co., Ltd.), EPICLON N-660, N-665, N -670, N-673, N-695, N-740, N-770, N-775 (the above are manufactured by Dainippon Ink Chemical Industry Co., Ltd.), EOCN-1020, EOCN-102S, EOCN-104S (the above are Nippon Kayaku Co., Ltd.), etc.

作為具有羧基之肉桂酸衍生物,例如可列舉下述式(1-1)~(1-5)

Figure 02_image005
(式中,R1 係表示氫原子、鹵素原子、C1 ~C6 烷基、C1 ~C6 烷氧基等)之任一者表示之化合物等。 又,作為具有羧基之肉桂酸衍生物,在上述之式[3]表示之單體,亦適合使用X1 為氫原子之化合物。Examples of the cinnamic acid derivatives having a carboxyl group include the following formulae (1-1) to (1-5)
Figure 02_image005
(In the formula, R 1 represents a compound represented by any one of a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, and the like). In addition, as the cinnamic acid derivative having a carboxyl group, a compound in which X 1 is a hydrogen atom is also suitably used as the monomer represented by the above formula [3].

上述式(1)表示之化合物可適當組合有機化學之定法合成。The compound represented by the above formula (1) can be synthesized by appropriate combination of methods of organic chemistry.

上述於側鏈具有環氧基之聚合物與特定之肉桂酸衍生物的反應生成物,可藉由將如上述之具有環氧基之聚合物與特定之肉桂酸衍生物,較佳為於觸媒的存在下,更佳為於適當之有機溶媒中進行反應來合成。 進行反應時所使用之肉桂酸衍生物的使用比例,相對於具有環氧基之聚合物所包含之環氧基1莫耳,較佳為0.01~1.5莫耳,更佳為0.05~1.3莫耳,再更佳為0.1~1.1莫耳。 作為可於此使用之有機觸媒,作為促進有機鹼或環氧化合物與酸酐的反應之所謂硬化促進劑,可使用公知之化合物。The reaction product of the above-mentioned polymer having an epoxy group in the side chain and a specific cinnamic acid derivative can be obtained by combining the above-mentioned polymer with an epoxy group and a specific cinnamic acid derivative, preferably in contact with each other. In the presence of a solvent, it is more preferable to perform a reaction in an appropriate organic solvent to synthesize. The use ratio of the cinnamic acid derivative used in the reaction is preferably 0.01-1.5 mol, more preferably 0.05-1.3 mol, relative to 1 mol of epoxy groups contained in the polymer having epoxy groups , and more preferably 0.1~1.1 mol. As an organic catalyst which can be used here, a well-known compound can be used as a so-called hardening accelerator which accelerates the reaction of an organic base or an epoxy compound and an acid anhydride.

作為上述有機鹼,例如可列舉如乙基胺、二乙基胺、哌嗪、哌啶、吡咯啶、吡咯之1~2級有機胺;如三乙基胺、三-n-丙基胺、三-n-丁基胺、吡啶、4-二甲基胺基吡啶、二氮雜聯環十一碳烯之3級有機胺;如四甲基氫氧化銨之4級有機胺等。此等之有機鹼當中,較佳為如三乙基胺、三-n-丙基胺、三-n-丁基胺、吡啶、4-二甲基胺基吡啶之3級有機胺;如四甲基氫氧化銨之4級有機胺。As the above-mentioned organic bases, for example, ethylamine, diethylamine, piperazine, piperidine, pyrrolidine, pyrrole's 1st to 2nd order organic amines; such as triethylamine, tri-n-propylamine, Tri-n-butylamine, pyridine, 4-dimethylaminopyridine, 3rd grade organic amine of diazabicycloundecene; such as 4th grade organic amine of tetramethylammonium hydroxide, etc. Among these organic bases, tertiary organic amines such as triethylamine, tri-n-propylamine, tri-n-butylamine, pyridine, 4-dimethylaminopyridine are preferred; The 4th grade organic amine of methyl ammonium hydroxide.

作為上述硬化促進劑,例如可列舉如苄基二甲基胺、2,4,6-參(二甲基胺基甲基)酚、環己基二甲基胺、三乙醇胺之3級胺;如2-甲基咪唑、2-n-庚基咪唑、2-n-十一烷基咪唑、2-苯基咪唑、2-苯基-4-甲基咪唑、1-苄基-2-甲基咪唑、1-苄基-2-苯基咪唑、1,2-二甲基咪唑、2-乙基-4-甲基咪唑、1-(2-氰基乙基)-2-甲基咪唑、1-(2-氰基乙基)-2-n-十一烷基咪唑、1-(2-氰基乙基)-2-苯基咪唑、1-(2-氰基乙基)-2-乙基-4-甲基咪唑、2-苯基-4-甲基-5-羥基甲基咪唑、2-苯基-4,5-二(羥基甲基)咪唑、1-(2-氰基乙基)-2-苯基-4,5-二[(2’-氰基乙氧基)甲基]咪唑、1-(2-氰基乙基)-2-n-十一烷基咪唑鎓偏苯三酸酯、1-(2-氰基乙基)-2-苯基咪唑鎓偏苯三酸酯、1-(2-氰基乙基)-2-乙基-4-甲基咪唑鎓偏苯三酸酯、2,4-二胺基-6-[2’-甲基咪唑基-(1’)]乙基-s-三嗪、2,4-二胺基-6-(2’-n-十一烷基咪唑基)乙基-s-三嗪、2,4-二胺基-6-[2’-乙基-4’-甲基咪唑基-(1’)]乙基-s-三嗪、2-甲基咪唑之異氰脲酸加成物、2-苯基咪唑之異氰脲酸加成物、2,4-二胺基-6-[2’-甲基咪唑基-(1’)]乙基-s-三嗪之異氰脲酸加成物之咪唑化合物;如二苯基膦、三苯基膦、亞磷酸三苯基之有機磷化合物;As the above-mentioned hardening accelerators, for example, tertiary amines such as benzyldimethylamine, 2,4,6-tris(dimethylaminomethyl)phenol, cyclohexyldimethylamine, and triethanolamine can be listed; 2-methylimidazole, 2-n-heptylimidazole, 2-n-undecylimidazole, 2-phenylimidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-methyl Imidazole, 1-benzyl-2-phenylimidazole, 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, 1-(2-cyanoethyl)-2-methylimidazole, 1-(2-cyanoethyl)-2-n-undecylimidazole, 1-(2-cyanoethyl)-2-phenylimidazole, 1-(2-cyanoethyl)-2 -Ethyl-4-methylimidazole, 2-phenyl-4-methyl-5-hydroxymethylimidazole, 2-phenyl-4,5-bis(hydroxymethyl)imidazole, 1-(2-cyano) ethyl)-2-phenyl-4,5-bis[(2'-cyanoethoxy)methyl]imidazole, 1-(2-cyanoethyl)-2-n-undecyl Imidazolium trimellitate, 1-(2-cyanoethyl)-2-phenylimidazolium trimellitate, 1-(2-cyanoethyl)-2-ethyl-4-methyl Imidazolium trimellitate, 2,4-diamino-6-[2'-methylimidazolyl-(1')]ethyl-s-triazine, 2,4-diamino-6 -(2'-n-Undecylimidazolyl)ethyl-s-triazine, 2,4-diamino-6-[2'-ethyl-4'-methylimidazolyl-(1' )] ethyl-s-triazine, isocyanuric acid adduct of 2-methylimidazole, isocyanuric acid adduct of 2-phenylimidazole, 2,4-diamino-6-[2 '-Methylimidazolyl-(1')] ethyl-s-triazine is an imidazole compound of isocyanuric acid adduct; such as diphenylphosphine, triphenylphosphine, organophosphorus of triphenylphosphite compound;

如苄基三苯基氯化鏻、四-n-丁基溴化鏻、甲基三苯基溴化鏻、乙基三苯基溴化鏻、n-丁基三苯基溴化鏻、四苯基溴化鏻、乙基三苯基碘化鏻、乙基三苯基鏻乙酸酯、四-n-丁基鏻o,o-二乙基硫逐二磷酸酯(Phosphorodithionate)、四-n-丁基鏻苯並三唑鹽、四-n-丁基鏻四氟硼酸鹽、四-n-丁基鏻四苯基硼酸鹽、四苯基鏻四苯基硼酸鹽之4級鏻鹽;如1,8-二氮雜聯環[5.4.0]十一碳烯-7或其有機酸鹽之二氮雜聯環烯烴;如辛酸鋅、辛酸錫、鋁乙醯基丙酮錯合物之有機金屬化合物;如四乙基溴化銨、四-n-丁基溴化銨、四乙基氯化銨、四-n-丁基氯化銨之4級銨鹽;如三氟化硼、硼酸三苯基之硼化合物;如氯化鋅、氯化錫之金屬鹵素化合物;雙氰胺或胺與環氧樹脂的加成物等之胺加成型促進劑等之高熔點分散型潛在性硬化促進劑;將前述咪唑化合物、有機磷化合物或4級鏻鹽等之硬化促進劑的表面以聚合物被覆之微膠囊型潛在性硬化促進劑;胺鹽型潛在性硬化劑促進劑;路易斯酸鹽、布朗斯台德酸(Bronsted acid)鹽等之高溫解離型之熱陽離子聚合型潛在性硬化促進劑等之潛在性硬化促進劑等。Such as benzyl triphenyl phosphonium chloride, tetra-n-butyl phosphonium bromide, methyl triphenyl phosphonium bromide, ethyl triphenyl phosphonium bromide, n-butyl triphenyl phosphonium bromide, tetra Phenylphosphonium bromide, ethyltriphenylphosphonium iodide, ethyltriphenylphosphonium acetate, tetra-n-butylphosphonium o,o-diethylthiodiphosphonate (Phosphorodithionate), tetra- 4th order phosphonium salt of n-butylphosphonium benzotriazole salt, tetra-n-butylphosphonium tetrafluoroborate, tetra-n-butylphosphonium tetraphenylborate, tetraphenylphosphonium tetraphenylborate ; Such as 1,8-diazabicyclo[5.4.0]undecene-7 or the diazabicycloalkene of its organic acid salt; such as zinc octoate, tin octoate, aluminum acetylacetone complex Organometallic compounds; such as tetraethylammonium bromide, tetra-n-butylammonium bromide, tetraethylammonium chloride, tetra-n-butylammonium chloride quaternary ammonium salt; such as boron trifluoride , boron compounds of triphenyl borate; metal halogen compounds such as zinc chloride and tin chloride; amine addition accelerators such as dicyandiamide or adducts of amines and epoxy resins, etc. High melting point dispersion potential Hardening accelerator; Microcapsule type latent hardening accelerator in which the surface of hardening accelerator such as the aforementioned imidazole compound, organophosphorus compound or quaternary phosphonium salt is coated with polymer; Amine salt type latent hardening agent accelerator; Lewis acid Salts, Bronsted acid salts, etc., high temperature dissociation type, thermal cationic polymerization type latent hardening accelerators, etc. latent hardening accelerators, etc.

此等當中,較佳為如四乙基溴化銨、四-n-丁基溴化銨、四乙基氯化銨、四-n-丁基氯化銨之4級銨鹽。Among these, quaternary ammonium salts such as tetraethylammonium bromide, tetra-n-butylammonium bromide, tetraethylammonium chloride, and tetra-n-butylammonium chloride are preferred.

作為觸媒的使用比例,相對於具有環氧基之聚合物100重量份,較佳為100重量份以下,更佳為0.01~100重量份,再更佳為0.1~20重量份。The usage ratio of the catalyst is preferably 100 parts by weight or less, more preferably 0.01 to 100 parts by weight, and even more preferably 0.1 to 20 parts by weight, relative to 100 parts by weight of the polymer having an epoxy group.

作為上述有機溶媒,例如可列舉烴化合物、醚化合物、酯化合物、酮化合物、醯胺化合物、醇化合物等。此等當中,醚化合物、酯化合物、酮化合物、醇化合物從原料及生成物的溶解性以及生成物之純化的容易性的觀點來看較佳。溶媒係固體成分濃度(反應溶液中之溶媒以外之成分之重量為溶液的全重量所佔有之比例)以較佳為成為0.1重量%以上,更佳為成為5~50重量%的量使用。As said organic solvent, a hydrocarbon compound, an ether compound, an ester compound, a ketone compound, an amide compound, an alcohol compound etc. are mentioned, for example. Among these, ether compounds, ester compounds, ketone compounds, and alcohol compounds are preferred from the viewpoints of solubility of raw materials and products, and ease of purification of products. The solid content concentration of the solvent (the weight of the components other than the solvent in the reaction solution is the ratio of the total weight of the solution) is preferably used in an amount of 0.1% by weight or more, more preferably 5 to 50% by weight.

反應溫度較佳為0~200℃,更佳為50~150℃。反應時間較佳為0.1~50小時,更佳為0.5~20小時。The reaction temperature is preferably 0 to 200°C, more preferably 50 to 150°C. The reaction time is preferably 0.1 to 50 hours, more preferably 0.5 to 20 hours.

如此進行,而得到含有具有環氧基之聚合物與特定之肉桂酸衍生物的反應生成物之溶液。此溶液可直接供於液晶配向劑的調製,除了單離溶液中所包含之聚合物外,並可供於液晶配向劑的調製,或除了純化單離之聚合物外,並可供於液晶配向劑的調製。In this way, a solution containing a reaction product of a polymer having an epoxy group and a specific cinnamic acid derivative is obtained. This solution can be directly used for the preparation of liquid crystal alignment agent, in addition to the polymer contained in the isolated solution, and can be used for the preparation of liquid crystal alignment agent, or in addition to purifying the isolated polymer, and can be used for liquid crystal alignment preparation of the agent.

又,在本實施形態,(A)成分之丙烯酸共聚物可為複數種之特定共聚物的混合物。Moreover, in this embodiment, the acrylic copolymer of (A) component may be a mixture of a plurality of specific copolymers.

如以上,在本發明,作為(A)成分,可使用高分子量之特定共聚物。又,(A)成分可為1種以上之特定共聚物的混合物。As described above, in the present invention, a high molecular weight specific copolymer can be used as the component (A). Moreover, (A) component may be a mixture of 1 or more types of specific copolymers.

<(B)成分> 在本發明之硬化膜形成組成物之(B)成分,係具有羥甲基或烷氧基甲基之交聯劑。 作為(B)成分之交聯劑,較佳為例如具有2個以上羥甲基或烷氧基甲基之交聯劑。作為具有此等之基的化合物,例如可列舉烷氧基甲基化甘脲、烷氧基甲基化苯并胍胺及烷氧基甲基化三聚氰胺等之羥甲基化合物。<(B) component> The (B) component of the cured film formation composition of this invention is a crosslinking agent which has a methylol group or an alkoxymethyl group. As a crosslinking agent of (B) component, the crosslinking agent which has, for example, two or more methylol groups or an alkoxymethyl group is preferable. Examples of compounds having such groups include methylol compounds such as alkoxymethylated glycoluril, alkoxymethylated benzoguanamine, and alkoxymethylated melamine.

作為烷氧基甲基化甘脲的具體例,例如可列舉1,3,4,6-肆(甲氧基甲基)甘脲、1,3,4,6-肆(丁氧基甲基)甘脲、1,3,4,6-肆(羥基甲基)甘脲、1,3-雙(羥基甲基)脲、1,1,3,3-肆(丁氧基甲基)脲、1,1,3,3-肆(甲氧基甲基)脲、1,3-雙(羥基甲基)-4,5-二羥基-2-四氫咪唑酮及1,3-雙(甲氧基甲基)-4,5-二甲氧基-2-四氫咪唑酮等。作為市售品,可列舉日本Cytec・Industries(股)(原三井Cytec(股))製甘脲化合物(商品名:CYMEL(註冊商標)1170、Powderlink(註冊商標)1174)等之化合物、甲基化脲樹脂(商品名:UFR(註冊商標)65)、丁基化脲樹脂(商品名:UFR(註冊商標)300、U-VAN10S60、U-VAN10R、U-VAN11HV)、DIC(股)(原大日本油墨化學工業(股))製脲/甲醛系樹脂(高縮合型、商品名:BECKAMINE(註冊商標)J-300S、同P-955、同N)等。Specific examples of the alkoxymethylated glycoluril include, for example, 1,3,4,6-tetra(methoxymethyl)glycoluril, 1,3,4,6-tetra(butoxymethyl) ) glycoluril, 1,3,4,6-tetra(hydroxymethyl) glycoluril, 1,3-bis(hydroxymethyl)urea, 1,1,3,3-tetra(butoxymethyl)urea , 1,1,3,3-tetra(methoxymethyl)urea, 1,3-bis(hydroxymethyl)-4,5-dihydroxy-2-tetrahydroimidazolone and 1,3-bis( Methoxymethyl)-4,5-dimethoxy-2-tetrahydroimidazolone, etc. Commercially available products include compounds such as glycoluril compounds (trade names: CYMEL (registered trademark) 1170, Powderlink (registered trademark) 1174) manufactured by Nippon Cytec・Industries Co., Ltd. (formerly Mitsui Cytec Co., Ltd.), methyl Urea resin (trade name: UFR (registered trademark) 65), butylated urea resin (trade name: UFR (registered trademark) 300, U-VAN10S60, U-VAN10R, U-VAN11HV), DIC (stock) (formerly Urea/formaldehyde resin (high condensation type, trade name: BECKAMINE (registered trademark) J-300S, same as P-955, same as N), manufactured by Dainippon Ink Chemical Industry Co., Ltd.

作為烷氧基甲基化苯并胍胺的具體例,可列舉四甲氧基甲基苯并胍胺等。作為市售品,可列舉日本Cytec・Industries(股)(原三井Cytec(股))製(商品名:CYMEL(註冊商標)1123)、三和化學(股)製(商品名:NIKALACK(註冊商標)BX-4000、同BX-37、同BL-60、同BX-55H)等。Specific examples of the alkoxymethylated benzoguanamine include tetramethoxymethylbenzoguanamine and the like. Commercially available products include Cytec・Industries Co., Ltd. (formerly Mitsui Cytec Co., Ltd.) (trade name: CYMEL (registered trademark) 1123), Sanwa Chemical Co., Ltd. (trade name: NIKALACK (registered trademark) ) BX-4000, same as BX-37, same as BL-60, same as BX-55H) etc.

作為烷氧基甲基化三聚氰胺的具體例,例如可列舉六甲氧基甲基三聚氰胺等。作為市售品,可列舉日本Cytec・Industries(股)(原三井Cytec(股))製甲氧基甲基型三聚氰胺化合物(商品名:CYMEL(註冊商標)300、同301、同303、同350)、丁氧基甲基型三聚氰胺化合物(商品名:MYCOAT(註冊商標)506、同508)、三和化學(股)製甲氧基甲基型三聚氰胺化合物(商品名:NIKALACK(註冊商標)MW-30、同MW-22、同MW-11、同MS-001、同MX-002、同MX-730、同MX-750、同MX-035)、丁氧基甲基型三聚氰胺化合物(商品名:NIKALACK(註冊商標)MX-45、同MX-410、同MX-302)等。As a specific example of alkoxymethylated melamine, hexamethoxymethyl melamine etc. are mentioned, for example. Examples of commercially available products include methoxymethyl-type melamine compounds (trade name: CYMEL (registered trademark) 300, same 301, same 303, and same 350 manufactured by Nippon Cytec・Industries Co., Ltd. (formerly Mitsui Cytec Co., Ltd.)) ), butoxymethyl-type melamine compound (trade name: MYCOAT (registered trademark) 506, Tong 508), methoxymethyl-type melamine compound (trade name: NIKALACK (registered trademark) MW) manufactured by Sanwa Chemical Co., Ltd. -30, same as MW-22, same as MW-11, same as MS-001, same as MX-002, same as MX-730, same as MX-750, same as MX-035), butoxymethyl melamine compound (trade name : NIKALACK (registered trademark) MX-45, same as MX-410, same as MX-302) etc.

又,亦可為縮合這般的胺基之氫原子被羥甲基或烷氧基甲基取代之三聚氰胺化合物、脲化合物、甘脲化合物及苯并胍胺化合物所得之化合物。例如可列舉從美國專利第6323310號所記載之三聚氰胺化合物及苯并胍胺化合物所製造之高分子量之化合物。作為前述三聚氰胺化合物之市售品,可列舉商品名:CYMEL(註冊商標)303等,作為前述苯并胍胺化合物之市售品,可列舉商品名:CYMEL(註冊商標)1123(以上為日本Cytec・Industries(股) (原三井Cytec(股))製)等。Moreover, the compound obtained by condensing such a melamine compound, a urea compound, a glycoluril compound, and a benzoguanamine compound in which the hydrogen atom of the amine group is substituted with a methylol group or an alkoxymethyl group may be used. For example, high molecular weight compounds produced from melamine compounds and benzoguanamine compounds described in US Pat. No. 6,323,310 can be mentioned. As a commercial item of the said melamine compound, a trade name: CYMEL (registered trademark) 303 etc. are mentioned, as a commercial item of the said benzoguanamine compound, a trade name: CYMEL (registered trademark) 1123 (above, Japan Cytec ・Industries (Co., Ltd.) (former Mitsui Cytec Co., Ltd.), etc.

進而,作為(B)成分之交聯劑,亦可使用:使用被N-羥基甲基丙烯醯胺、N-甲氧基甲基甲基丙烯醯胺、N-乙氧基甲基丙烯醯胺、N-丁氧基甲基甲基丙烯醯胺等之羥基甲基(亦即羥甲基)或烷氧基甲基取代之丙烯醯胺化合物或甲基丙烯醯胺化合物所製造之聚合物。Furthermore, as a crosslinking agent of the (B) component, N-hydroxymethyl acrylamide, N-methoxymethylmethacrylamide, N-ethoxymethyl acrylamide can also be used. , N-butoxymethyl methacrylamide and other hydroxymethyl (ie methylol) or alkoxymethyl substituted acrylamide compounds or methacrylamide compounds produced polymers.

作為這般的聚合物,例如可列舉聚(N-丁氧基甲基丙烯醯胺)、N-丁氧基甲基丙烯醯胺與苯乙烯的共聚物、N-羥基甲基甲基丙烯醯胺與甲基甲基丙烯酸酯的共聚物、N-乙氧基甲基甲基丙烯醯胺與苄基甲基丙烯酸酯的共聚物,及N-丁氧基甲基丙烯醯胺與苄基甲基丙烯酸酯與2-羥基丙基甲基丙烯酸酯的共聚物等。Examples of such polymers include poly(N-butoxymethacrylamide), copolymers of N-butoxymethacrylamide and styrene, and N-hydroxymethylmethacrylamide. Copolymers of amines and methmethacrylates, copolymers of N-ethoxymethylmethacrylamides and benzyl methacrylates, and N-butoxymethacrylamides and benzylmethyl Copolymer of acrylic acid ester and 2-hydroxypropyl methacrylate, etc.

這般的聚合物的重量平均分子量(聚苯乙烯換算值)為1,000~500,000,較佳為2,000~200,000,更佳為3,000~150,000,再更佳為3,000~50,000。The weight average molecular weight (in terms of polystyrene) of such a polymer is 1,000 to 500,000, preferably 2,000 to 200,000, more preferably 3,000 to 150,000, still more preferably 3,000 to 50,000.

此等之交聯劑可單獨或組合2種以上使用。These crosslinking agents can be used alone or in combination of two or more.

在本發明之硬化膜形成組成物的(B)成分之交聯劑的含量,根據(A)成分之聚合物100質量份,較佳為1質量份~500質量份,更佳為5質量份~400質量份。The content of the crosslinking agent of the component (B) in the cured film forming composition of the present invention is preferably 1 part by mass to 500 parts by mass, more preferably 5 parts by mass, based on 100 parts by mass of the polymer of the component (A) ~400 parts by mass.

<(C)成分> 本發明之組成物係含有具有與烷氧基矽烷基部位不同之熱交聯性基之烷氧基矽烷。作為上述烷氧基矽烷,較佳為下述式(5)表示之矽烷化合物。

Figure 02_image007
式(5)中,R9 係表示甲基或乙基。X係表示水解性基。Y係表示熱交聯性基。m為0~3之整數。n為0~3之整數。<(C)component> The composition of this invention contains the alkoxysilane which has a thermally crosslinkable group different from an alkoxysilyl group part. As said alkoxysilane, the silane compound represented by following formula (5) is preferable.
Figure 02_image007
In formula (5), R 9 represents a methyl group or an ethyl group. X represents a hydrolyzable group. Y represents a thermally crosslinkable group. m is an integer from 0 to 3. n is an integer from 0 to 3.

作為X表示之水解性基,可列舉鹵素原子、碳數1~3之烷氧基、碳數2~4之烷氧基烷氧基等。作為上述鹵素原子,可列舉氯原子、溴原子等。碳數1~3之烷氧基較佳為直鏈狀或分枝狀者,具體而言,為甲氧基、乙氧基、n-丙氧基及異丙氧基。又,作為碳數2~4之烷氧基烷氧基,具體而言,為甲氧基甲氧基、2-甲氧基乙氧基、乙氧基甲氧基及2-乙氧基乙氧基。Examples of the hydrolyzable group represented by X include a halogen atom, an alkoxy group having 1 to 3 carbon atoms, and an alkoxyalkoxy group having 2 to 4 carbon atoms. As said halogen atom, a chlorine atom, a bromine atom, etc. are mentioned. The alkoxy group having 1 to 3 carbon atoms is preferably linear or branched, and specifically, is a methoxy group, an ethoxy group, an n-propoxy group, and an isopropoxy group. In addition, as the alkoxyalkoxy group having 2 to 4 carbon atoms, specifically, methoxymethoxy, 2-methoxyethoxy, ethoxymethoxy, and 2-ethoxyethyl Oxygen.

作為與Y表示之烷氧基矽烷基部位不同之熱交聯性基,可列舉羥基、巰基、脲基、異氰酸酯基、具有環氧構造之基、具有環氧丙烷(Oxetane)構造之基、胺基及丙烯醯基氧基(CH2 =CHCOO)等。其中,具有脲基、異氰酸酯基及環氧基之基,以較少之添加量表現密著性這點來看較佳。Examples of thermally crosslinkable groups different from the alkoxysilyl moiety represented by Y include a hydroxyl group, a mercapto group, a urea group, an isocyanate group, a group having an epoxy structure, a group having a propylene oxide (Oxetane) structure, and an amine. group and acryloxy group (CH 2 =CHCOO) and the like. Among them, groups having a urea group, an isocyanate group, and an epoxy group are preferable in that they exhibit adhesion with a small amount added.

作為(C)成分之具有交聯性基之烷氧基矽烷,具體而言,可列舉3-羥基丙基三氯矽烷、3-羥基丙基三甲氧基矽烷、3-羥基丙基三乙氧基矽烷、3-羥基丙基甲基二甲氧基矽烷、3-羥基丙基甲基二乙氧基矽烷、3-巰基丙基三甲氧基矽烷、3-巰基丙基三乙氧基矽烷、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基甲基二乙氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、3-異氰酸基丙基三甲氧基矽烷、3-異氰酸基丙基三乙氧基矽烷、3-異氰酸基丙基甲基二甲氧基矽烷、3-異氰酸基丙基甲基二乙氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽烷、3-縮水甘油氧基丙基甲基二乙氧基矽烷、3-縮水甘油氧基丙基三乙氧基矽烷、3-(3-乙基環氧丙烷(Oxetane)-3-基甲基氧基)丙基三甲氧基矽烷、3-(3-乙基環氧丙烷(Oxetane)-3-基甲基氧基)丙基三乙氧基矽烷、3-(3-乙基環氧丙烷(Oxetane)-3-基甲基氧基)丙基甲基二甲氧基矽烷、3-(3-乙基環氧丙烷(Oxetane)-3-基甲基氧基)丙基甲基二乙氧基矽烷、3-胺基丙基三甲氧基矽烷、3-(胺基丙基三乙氧基矽烷、3-胺基丙基甲基二甲氧基矽烷、3-胺基丙基甲基二乙氧基矽烷、3-丙烯醯基氧基丙基三甲氧基矽烷、3-丙烯醯基氧基丙基三乙氧基矽烷、3-丙烯醯基氧基丙基甲基二甲氧基矽烷、3-丙烯醯基氧基丙基甲基二乙氧基矽烷等。Specific examples of the alkoxysilane having a crosslinkable group of the component (C) include 3-hydroxypropyltrichlorosilane, 3-hydroxypropyltrimethoxysilane, and 3-hydroxypropyltriethoxy Silane, 3-hydroxypropylmethyldimethoxysilane, 3-hydroxypropylmethyldiethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-mercaptopropyltriethoxysilane, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropylmethyldiethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, 3 -Isocyanatopropyltrimethoxysilane, 3-Isocyanatopropyltriethoxysilane, 3-Isocyanatopropylmethyldimethoxysilane, 3-Isocyanatopropyl Methyldiethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane , 3-(3-ethyl oxide propane (Oxetane)-3-ylmethyloxy) propyl trimethoxysilane, 3-(3-ethyl oxide propane (Oxetane)-3-yl methyloxy propyl) propyl triethoxy silane, 3-(3-ethyl propylene oxide (Oxetane)-3-ylmethyloxy) propyl methyl dimethoxy silane, 3-(3-ethyl ring Oxetane-3-ylmethyloxy)propylmethyldiethoxysilane, 3-aminopropyltrimethoxysilane, 3-(aminopropyltriethoxysilane, 3- Aminopropylmethyldimethoxysilane, 3-aminopropylmethyldiethoxysilane, 3-acryloyloxypropyltrimethoxysilane, 3-acryloyloxypropyltrimethoxysilane Ethoxysilane, 3-acryloyloxypropylmethyldimethoxysilane, 3-acryloyloxypropylmethyldiethoxysilane, etc.

此等當中,特佳為3-巰基丙基三甲氧基矽烷、3-巰基丙基三乙氧基矽烷、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基甲基二乙氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、3-異氰酸基丙基三甲氧基矽烷、3-異氰酸基丙基三乙氧基矽烷、3-異氰酸基丙基甲基二甲氧基矽烷、3-異氰酸基丙基甲基二乙氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽烷、3-縮水甘油氧基丙基甲基二乙氧基矽烷、3-縮水甘油氧基丙基三乙氧基矽烷等。 作為具有上述(C)成分之交聯性基的烷氧基矽烷,可使用市售品。Among them, particularly preferred are 3-mercaptopropyltrimethoxysilane, 3-mercaptopropyltriethoxysilane, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropylmethyldiethyl Oxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, 3-isocyanatopropyltrimethoxysilane, 3-isocyanatopropyltriethyl Oxysilane, 3-Isocyanatopropylmethyldimethoxysilane, 3-Isocyanatopropylmethyldiethoxysilane, 3-Glycidyloxypropyltrimethoxysilane, 3 - Glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, etc. As an alkoxysilane which has the crosslinkable group of the said (C)component, a commercial item can be used.

具有在本發明之組成物之(C)成分的交聯性基之烷氧基矽烷的含量,相對於(A)成分之聚合物100質量份,較佳為0.001~20質量份,更佳為0.01~8質量份,再更佳為0.05~4質量份。The content of the alkoxysilane having a crosslinkable group in the (C) component of the composition of the present invention is preferably 0.001 to 20 parts by mass, more preferably 0.001 to 20 parts by mass relative to 100 parts by mass of the polymer of the (A) component 0.01 to 8 parts by mass, more preferably 0.05 to 4 parts by mass.

<(D)成分> 本發明之硬化膜形成組成物除了前述(A)成分、(B)成分及(C)成分,進而作為(D)成分,可含有交聯觸媒。<(D)component> The cured film formation composition of this invention may contain a crosslinking catalyst as (D)component in addition to said (A) component, (B) component, and (C)component.

作為(D)成分之交聯觸媒,例如可適合使用酸或熱酸產生劑。此(D)成分在促進本發明之硬化膜形成組成物的熱硬化反應為有效。As a crosslinking catalyst of (D)component, for example, an acid or a thermal acid generator can be used suitably. This (D)component is effective in promoting the thermosetting reaction of the cured film-forming composition of this invention.

(D)成分具體而言,作為上述酸,可列舉含有磺酸基之化合物、鹽酸或其鹽。而且,作為上述熱酸產生劑,若為於加熱處理時進行熱分解,而產生酸之化合物,亦即若為於溫度80℃至250℃進行熱分解,而產生酸之化合物,則並非被特別限定者。(D) Component specifically, as said acid, the compound containing a sulfonic acid group, hydrochloric acid, or its salt are mentioned. In addition, as the thermal acid generator, if it is a compound that thermally decomposes during heat treatment to generate an acid, that is, a compound that thermally decomposes at a temperature of 80°C to 250°C to generate an acid, it is not particularly limited. Qualifier.

作為上述酸的具體例,例如可列舉鹽酸或其鹽;甲烷磺酸、乙烷磺酸、丙烷磺酸、丁烷磺酸、戊烷磺酸、辛烷磺酸、苯磺酸、p-甲苯磺酸、樟腦磺酸、三氟甲烷磺酸、p-酚磺酸、2-萘磺酸、均三甲苯磺酸、p-二甲苯-2-磺酸、m-二甲苯-2-磺酸、4-乙基苯磺酸、1H,1H,2H,2H-全氟辛烷磺酸、全氟(2-乙氧基乙烷)磺酸、五氟乙烷磺酸、九氟丁烷-1-磺酸、十二烷基苯磺酸等之含有磺酸基之化合物或其水合物或鹽等。Specific examples of the acid include hydrochloric acid or its salt; methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid, pentanesulfonic acid, octanesulfonic acid, benzenesulfonic acid, and p-toluene Sulfonic acid, camphorsulfonic acid, trifluoromethanesulfonic acid, p-phenolsulfonic acid, 2-naphthalenesulfonic acid, mesitylenesulfonic acid, p-xylene-2-sulfonic acid, m-xylene-2-sulfonic acid , 4-ethylbenzenesulfonic acid, 1H,1H,2H,2H-perfluorooctanesulfonic acid, perfluoro(2-ethoxyethane)sulfonic acid, pentafluoroethanesulfonic acid, nonafluorobutane- A sulfonic acid group-containing compound such as 1-sulfonic acid and dodecylbenzenesulfonic acid, or a hydrate or salt thereof.

又,作為藉由熱產生酸之化合物,例如可列舉雙(對甲苯磺醯基(Tosyl)氧基)乙烷、雙(對甲苯磺醯基(Tosyl)氧基)丙烷、雙(對甲苯磺醯基(Tosyl)氧基)丁烷、p-硝基苄基甲苯磺酸酯、o-硝基苄基甲苯磺酸酯、1,2,3-伸苯基參(甲基磺酸酯)、p-甲苯磺酸吡啶鎓鹽、p-甲苯磺酸嗎啉鎓鹽、p-甲苯磺酸乙基酯、p-甲苯磺酸丙基酯、p-甲苯磺酸丁基酯、p-甲苯磺酸異丁基酯、p-甲苯磺酸甲基酯、p-甲苯磺酸苯乙基酯、氰基甲基p-甲苯磺酸酯、2,2,2-三氟乙基p-甲苯磺酸酯、2-羥基丁基p-甲苯磺酸酯、N-乙基-p-甲苯磺醯胺,進而可列舉下述式表示之化合物:

Figure 02_image009
Further, examples of compounds that generate an acid by heat include bis(p-toluenesulfonyl (Tosyl)oxy)ethane, bis(p-toluenesulfonyl (Tosyl)oxy)propane, bis(p-toluenesulfonyl) Acetyl (Tosyl) oxy) butane, p-nitrobenzyl tosylate, o-nitrobenzyl tosylate, 1,2,3-phenylene (methylsulfonate) , p-toluenesulfonic acid pyridinium salt, p-toluenesulfonic acid morpholinium salt, p-toluenesulfonic acid ethyl ester, p-toluenesulfonic acid propyl ester, p-toluenesulfonic acid butyl ester, p-toluenesulfonate Isobutyl sulfonate, methyl p-toluenesulfonate, phenethyl p-toluenesulfonate, cyanomethyl p-toluenesulfonate, 2,2,2-trifluoroethyl p-toluene Sulfonate, 2-hydroxybutyl p-toluenesulfonate, N-ethyl-p-toluenesulfonamide, and further compounds represented by the following formula:
Figure 02_image009

Figure 02_image011
Figure 02_image011

Figure 02_image013
Figure 02_image013

Figure 02_image015
Figure 02_image015

Figure 02_image017
Figure 02_image017

Figure 02_image019
等。
Figure 02_image019
Wait.

在本發明之硬化膜形成組成物之(D)成分的含量,相對於(A)成分之聚合物及(B)成分之交聯劑的合計量之100質量份,較佳為0.01質量份~20質量份,更佳為0.1質量份~15質量份,再更佳為0.5質量份~10質量份。藉由將(D)成分的含量定為0.01質量份以上,可賦予充分之熱硬化性及溶劑耐性。惟,較20質量份更多時,有降低組成物之保存安定性的情況。The content of the component (D) in the cured film-forming composition of the present invention is preferably 0.01 part by mass to 100 parts by mass of the total amount of the polymer of the component (A) and the crosslinking agent of the component (B) 20 parts by mass, more preferably 0.1 parts by mass to 15 parts by mass, still more preferably 0.5 parts by mass to 10 parts by mass. By making content of (D)component 0.01 mass part or more, sufficient thermosetting property and solvent resistance can be provided. However, when it is more than 20 parts by mass, the storage stability of the composition may be lowered.

<(E)成分> 本發明作為(E)成分,亦可含有:具有一個以上之自由基聚合性基,並具有選自羥基及N-烷氧基甲基中之基的化合物。(E)成分用作提昇所形成之硬化膜與液晶層的接著性之成分(以下,亦稱為密著提昇成分)。<(E) Ingredient> The present invention may contain, as the component (E), a compound having one or more radically polymerizable groups and having a group selected from a hydroxyl group and an N-alkoxymethyl group. (E) A component is used as a component (henceforth, it is also called an adhesion improvement component) which improves the adhesiveness of the formed cured film and a liquid crystal layer.

將從含有(E)成分之本實施形態的硬化膜形成組成物所形成之硬化膜作為配向材料使用時,如提昇配向材料與聚合性液晶之層的密著性,可將聚合性液晶之聚合性官能基與配向材料之交聯反應部位藉由共價鍵鏈接。其結果,層合於本實施形態的配向材料上硬化之聚合性液晶而成之本實施形態的相位差材料,即使於高溫高質的條件下,亦可維持強密著性,可顯示對於剝離等之高耐久性。When the cured film formed from the cured film forming composition of the present embodiment containing the component (E) is used as an alignment material, if the adhesion between the alignment material and the layer of the polymerizable liquid crystal is improved, the polymerizable liquid crystal can be polymerized The functional group and the cross-linking reaction site of the alignment material are linked by covalent bonds. As a result, the retardation material of the present embodiment, which is formed by laminating the hardened polymerizable liquid crystal on the alignment material of the present embodiment, can maintain strong adhesion even under high temperature and high-quality conditions, and can exhibit resistance to peeling. Equally high durability.

作為(E)成分,較佳為具有選自羥基及N-烷氧基甲基之基、與聚合性基之單體及聚合物。 作為這般的(E)成分,可列舉具有羥基與(甲基)丙烯醯基之化合物、具有N-烷氧基甲基與(甲基)丙烯醯基之化合物、具有N-烷氧基甲基與(甲基)丙烯醯基之聚合物等。以下分別顯示具體例。As the component (E), a monomer and a polymer having a group selected from a hydroxyl group, an N-alkoxymethyl group, and a polymerizable group are preferable. As such (E) component, the compound which has a hydroxyl group and (meth)acryloyl group, the compound which has N-alkoxymethyl group and (meth)acryloyl group, the compound which has N-alkoxymethyl group, Polymers of (meth)acryloyl and (meth)acryloyl groups, etc. Specific examples are shown below.

作為(E)成分之一例,可列舉含有羥基之多官能丙烯酸酯(以下亦稱為含有羥基之多官能丙烯酸酯)。 作為(E)成分之例即含有羥基之多官能丙烯酸酯,例如可列舉季戊四醇三丙烯酸酯及二季戊四醇五丙烯酸酯等。As one example of the component (E), a hydroxyl group-containing polyfunctional acrylate (hereinafter also referred to as a hydroxyl group-containing polyfunctional acrylate) can be mentioned. As an example of (E) component, the polyfunctional acrylate containing a hydroxyl group is mentioned, for example, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, etc. are mentioned.

作為(E)成分之一例,亦可列舉具有1個丙烯醯基、與1個以上羥基之化合物。可列舉具有這般的1個丙烯醯基、與1個以上羥基之化合物的較佳之例。尚,(E)成分之化合物並非被限定於以下之化合物例者。As an example of (E) component, the compound which has one acrylyl group and one or more hydroxyl groups can also be mentioned. A preferable example of the compound which has such one acrylyl group and one or more hydroxyl groups is mentioned. Furthermore, the compound of the component (E) is not limited to the following compound examples.

Figure 02_image021
(上述式中,R11 係表示氫原子或甲基,m係表示1~10之整數)。
Figure 02_image021
(In the above formula, R 11 represents a hydrogen atom or a methyl group, and m represents an integer of 1 to 10).

又,作為(E)成分之化合物,可列舉具有至少一個於1分子中包含C=C雙鍵之聚合性基、與至少一個N-烷氧基甲基之化合物。Moreover, as a compound of (E) component, the compound which has at least 1 polymerizable group containing a C=C double bond in 1 molecule, and at least 1 N-alkoxymethyl group is mentioned.

作為包含C=C雙鍵之聚合性基,可列舉丙烯醯基、甲基丙烯醯基、乙烯基、烯丙基、馬來醯亞胺基等。As a polymerizable group containing a C=C double bond, an acryl group, a methacryl group, a vinyl group, an allyl group, a maleimide group, etc. are mentioned.

作為N-烷氧基甲基之N,亦即氮原子,可列舉與醯胺之氮原子、硫醯胺之氮原子、脲之氮原子、硫脲之氮原子、胺基甲酸酯之氮原子、含氮雜環之氮原子的相鄰位鍵結之氮原子等。據此,作為N-烷氧基甲基,可列舉於選自與醯胺之氮原子、硫醯胺之氮原子、脲之氮原子、硫脲之氮原子、胺基甲酸酯之氮原子、含氮雜環之氮原子的相鄰位鍵結之氮原子等之氮原子與烷氧基甲基鍵結之構造。The N, that is, the nitrogen atom of the N-alkoxymethyl group, includes the nitrogen atom of amide, the nitrogen atom of thioamide, the nitrogen atom of urea, the nitrogen atom of thiourea, and the nitrogen of urethane. atom, nitrogen atom bonded to the adjacent position of nitrogen atom of nitrogen-containing heterocyclic ring, etc. Accordingly, the N-alkoxymethyl group may be selected from the group consisting of a nitrogen atom of amide, a nitrogen atom of thioamide, a nitrogen atom of urea, a nitrogen atom of thiourea, and a nitrogen atom of urethane. , A structure in which a nitrogen atom such as a nitrogen atom bonded to the adjacent position of a nitrogen atom of a nitrogen-containing heterocyclic ring is bonded to an alkoxymethyl group.

作為(E)成分,雖若為具有上述之基者即可,但較佳為例如可列舉下述之式(X1)表示之化合物。

Figure 02_image023
(式中,R31 係表示氫原子或甲基,R32 係表示氫原子,或是直鏈或分枝之碳原子數1至10之烷基)As (E) component, although what has the above-mentioned group may be sufficient, for example, the compound represented by following formula (X1) is mentioned preferably.
Figure 02_image023
(In the formula, R 31 represents a hydrogen atom or a methyl group, and R 32 represents a hydrogen atom, or a straight-chain or branched alkyl group having 1 to 10 carbon atoms)

作為上述烷基,例如可列舉甲基、乙基、n-丙基、異丙基、n-丁基、異丁基、sec-丁基、tert-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、1,2-二甲基-n-丙基、2,2-二甲基-n-丙基、1-乙基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、3-甲基-n-戊基、4-甲基-n-戊基、1,1-二甲基-n-丁基、1,2-二甲基-n-丁基、1,3-二甲基-n-丁基、2,2-二甲基-n-丁基、2,3-二甲基-n-丁基、3,3-二甲基-n-丁基、1-乙基-n-丁基、2-乙基-n-丁基、1,1,2-三甲基-n-丙基、1,2,2-三甲基-n-丙基、1-乙基-1-甲基-n-丙基、1-乙基-2-甲基-n-丙基、n-庚基、1-甲基-n-己基、2-甲基-n-己基、3-甲基-n-己基、1,1-二甲基-n-戊基、1,2-二甲基-n-戊基、1,3-二甲基-n-戊基、2,2-二甲基-n-戊基、2,3-二甲基-n-戊基、3,3-二甲基-n-戊基、1-乙基-n-戊基、2-乙基-n-戊基、3-乙基-n-戊基、1-甲基-1-乙基-n-丁基、1-甲基-2-乙基-n-丁基、1-乙基-2-甲基-n-丁基、2-甲基-2-乙基-n-丁基、2-乙基-3-甲基-n-丁基、n-辛基、1-甲基-n-庚基、2-甲基-n-庚基、3-甲基-n-庚基、1,1-二甲基-n-己基、1,2-二甲基-n-己基、1,3-二甲基-n-己基、2,2-二甲基-n-己基、2,3-二甲基-n-己基、3,3-二甲基-n-己基、1-乙基-n-己基、2-乙基-n-己基、3-乙基-n-己基、1-甲基-1-乙基-n-戊基、1-甲基-2-乙基-n-戊基、1-甲基-3-乙基-n-戊基、2-甲基-2-乙基-n-戊基、2-甲基-3-乙基-n-戊基、3-甲基-3-乙基-n-戊基、n-壬基、n-癸基等。Examples of the alkyl group include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, and 1-methyl. yl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1-dimethyl-n-propyl, 1,2-dimethyl-n- propyl, 2,2-dimethyl-n-propyl, 1-ethyl-n-propyl, n-hexyl, 1-methyl-n-pentyl, 2-methyl-n-pentyl, 3-Methyl-n-pentyl, 4-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1,2-dimethyl-n-butyl, 1,3- Dimethyl-n-butyl, 2,2-dimethyl-n-butyl, 2,3-dimethyl-n-butyl, 3,3-dimethyl-n-butyl, 1- Ethyl-n-butyl, 2-ethyl-n-butyl, 1,1,2-trimethyl-n-propyl, 1,2,2-trimethyl-n-propyl, 1- Ethyl-1-methyl-n-propyl, 1-ethyl-2-methyl-n-propyl, n-heptyl, 1-methyl-n-hexyl, 2-methyl-n-hexyl , 3-methyl-n-hexyl, 1,1-dimethyl-n-pentyl, 1,2-dimethyl-n-pentyl, 1,3-dimethyl-n-pentyl, 2 ,2-dimethyl-n-pentyl, 2,3-dimethyl-n-pentyl, 3,3-dimethyl-n-pentyl, 1-ethyl-n-pentyl, 2- Ethyl-n-pentyl, 3-ethyl-n-pentyl, 1-methyl-1-ethyl-n-butyl, 1-methyl-2-ethyl-n-butyl, 1- Ethyl-2-methyl-n-butyl, 2-methyl-2-ethyl-n-butyl, 2-ethyl-3-methyl-n-butyl, n-octyl, 1- Methyl-n-heptyl, 2-methyl-n-heptyl, 3-methyl-n-heptyl, 1,1-dimethyl-n-hexyl, 1,2-dimethyl-n- Hexyl, 1,3-dimethyl-n-hexyl, 2,2-dimethyl-n-hexyl, 2,3-dimethyl-n-hexyl, 3,3-dimethyl-n-hexyl, 1-Ethyl-n-hexyl, 2-ethyl-n-hexyl, 3-ethyl-n-hexyl, 1-methyl-1-ethyl-n-pentyl, 1-methyl-2-ethyl yl-n-pentyl, 1-methyl-3-ethyl-n-pentyl, 2-methyl-2-ethyl-n-pentyl, 2-methyl-3-ethyl-n-pentyl group, 3-methyl-3-ethyl-n-pentyl, n-nonyl, n-decyl, etc.

作為上述式(X1)表示之化合物的具體例,可列舉被N-羥基甲基(甲基)丙烯醯胺、N-甲氧基甲基(甲基)丙烯醯胺、N-乙氧基甲基(甲基)丙烯醯胺、N-丁氧基甲基(甲基)丙烯醯胺等之羥基甲基或烷氧基甲基取代之丙烯醯胺化合物或甲基丙烯醯胺化合物。尚,所謂(甲基)丙烯醯胺,係意指甲基丙烯醯胺與丙烯醯胺雙方。Specific examples of the compound represented by the above formula (X1) include N-hydroxymethyl (meth)acrylamide, N-methoxymethyl (meth)acrylamide, N-ethoxymethyl Hydroxymethyl or alkoxymethyl substituted acrylamide compounds or methacrylamide compounds such as N-butoxymethyl (meth) acrylamide and N-butoxymethyl (meth) acrylamide. In addition, the so-called (meth)acrylamide means both methacrylamide and acrylamide.

作為 (E)成分之包含C=C雙鍵之聚合性基與具有N-烷氧基甲基之化合物的另一態樣,較佳為例如可列舉下述之式(X2)表示之化合物。

Figure 02_image025
式中,R51 係表示氫原子或甲基。 R52 係表示碳原子數2至20之烷基、碳原子數5至6之1價脂肪族環基,或是包含碳原子數5至6之脂肪族環之1價脂肪族基,可於構造中包含醚鍵。 R53 係表示直鏈或分枝鏈之碳原子數2至20之伸烷基、碳原子數5至6之2價脂肪族環基,或是包含碳原子數5至6之脂肪族環之2價脂肪族基,可於構造中包含醚鍵。 R54 係表示直鏈或分枝鏈之碳原子數1至20之2價至9價脂肪族基、碳原子數5至6之2價至9價脂肪族環基,或是包含碳原子數5至6之脂肪族環之2價至9價脂肪族基,此等之基的一個亞甲基或複數個彼此不相鄰之亞甲基可被醚鍵取代。 Z係表示>NCOO-或-OCON<(於此「-」係表示鍵結部為一個。又,「>」「<」係表示鍵結部為2個,且於任一個鍵結部鍵結烷氧基甲基(亦即-OR52 基))。 r為2以上9以下之自然數。As another aspect of the polymerizable group containing the C=C double bond of the component (E) and the compound having an N-alkoxymethyl group, for example, a compound represented by the following formula (X2) is preferably used.
Figure 02_image025
In the formula, R 51 represents a hydrogen atom or a methyl group. R 52 represents an alkyl group with 2 to 20 carbon atoms, a monovalent aliphatic ring group with 5 to 6 carbon atoms, or a monovalent aliphatic group containing an aliphatic ring with 5 to 6 carbon atoms. The construction contains ether bonds. R 53 represents a straight-chain or branched chain alkylene group with 2 to 20 carbon atoms, a divalent aliphatic ring group with 5 to 6 carbon atoms, or an aliphatic ring containing 5 to 6 carbon atoms. A divalent aliphatic group may contain an ether bond in its structure. R 54 represents a linear or branched bivalent to 9-valent aliphatic group with 1 to 20 carbon atoms, a 2- to 9-valent aliphatic cyclic group with 5 to 6 carbon atoms, or a group containing carbon atoms Divalent to 9-valent aliphatic groups of the aliphatic rings of 5 to 6, one methylene group or a plurality of methylene groups not adjacent to each other in these groups may be substituted with ether bonds. Z means >NCOO- or -OCON< (here, "-" means that there is one key part. Also, ">" and "<" means that there are two key parts, and they are connected to any key part. alkoxymethyl (ie -OR 52 group)). r is a natural number of 2 or more and 9 or less.

作為在R53 之定義的碳原子數2至20之伸烷基的具體例,可列舉從碳原子數2至20之烷基,進一步去除1個氫原子之2價之基。 又,作為在R54 之定義的碳原子數1至20之2價至9價之脂肪族基的具體例,可列舉從碳原子數1至20之烷基,進一步去除1至8個氫原子之2價至9價之基。Specific examples of the alkylene group having 2 to 20 carbon atoms as defined in R 53 include divalent groups obtained by removing one hydrogen atom from the alkyl group having 2 to 20 carbon atoms. In addition, as a specific example of the aliphatic group having 1 to 20 carbon atoms and a 2- to 9-valent aliphatic group defined in R 54 , there can be mentioned an alkyl group having 1 to 20 carbon atoms and further 1 to 8 hydrogen atoms are removed. 2 price to 9 price basis.

碳原子數1之烷基為甲基,又,作為碳原子數2至20之烷基的具體例,可將乙基、n-丙基、i-丙基、n-丁基、i-丁基、s-丁基、t-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、1,1-二甲基-n-丁基、1-乙基-n-丁基、1,1,2-三甲基-n-丙基、n-庚基、n-辛基、n-壬基、n-癸基、n-十一烷基、n-十二烷基、n-十三烷基、n-十四烷基、n-十五烷基、n-十六烷基、n-十七烷基、n-十八烷基、n-十九烷基、n-二十烷基、環戊基、環己基、該等之一種或複數種於碳原子數20為止的範圍鍵結之基、與此等之基的一個亞甲基或複數個彼此不相鄰之亞甲基被醚鍵取代之基等作為一例列舉。The alkyl group having 1 carbon atoms is a methyl group, and as specific examples of the alkyl group having 2 to 20 carbon atoms, ethyl, n-propyl, i-propyl, n-butyl, i-butyl can be used. base, s-butyl, t-butyl, n-pentyl, 1-methyl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1 -Dimethyl-n-propyl, n-hexyl, 1-methyl-n-pentyl, 2-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1-ethyl yl-n-butyl, 1,1,2-trimethyl-n-propyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n -dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n- Nonadecyl group, n-eicosyl group, cyclopentyl group, cyclohexyl group, one or more of these groups bonded to the range up to 20 carbon atoms, a methylene group or a group of these groups A group in which a plurality of methylene groups that are not adjacent to each other are substituted by ether bonds, etc., are exemplified.

此等當中,較佳為碳原子數2至10之伸烷基,R53 為伸乙基,R54 為伸己基,從原料的取得性等之點來看特佳。Among these, an alkylene group having 2 to 10 carbon atoms is preferable, R53 is an ethylidene group, and R54 is a hexylene group, and it is particularly preferable from the viewpoint of availability of raw materials and the like.

作為在R52 之定義的碳原子數1至20之烷基的具體例,可列舉在R53 之定義的碳原子數2至20之烷基的具體例及甲基。此等當中,較佳為碳原子數1至6之烷基,特佳為甲基、乙基、n-丙基或n-丁基。Specific examples of the alkyl group having 1 to 20 carbon atoms defined in R 52 include specific examples of the alkyl group having 2 to 20 carbon atoms defined in R 53 and a methyl group. Among these, an alkyl group having 1 to 6 carbon atoms is preferable, and a methyl group, an ethyl group, an n-propyl group or an n-butyl group is particularly preferable.

作為r,雖可列舉2以上9以下之自然數,但其中,較佳為2至6。Although a natural number of 2 or more and 9 or less can be mentioned as r, among them, 2 to 6 are preferable.

在本發明之實施形態的硬化膜形成組成物之(E)成分的含量,相對於(A)成分之聚合物及(B)成分之交聯劑的合計量之100質量份,較佳為1質量份~100質量份,更佳為5質量份~70質量份。The content of the component (E) in the cured film-forming composition of the embodiment of the present invention is preferably 1 with respect to 100 parts by mass of the total amount of the polymer of the component (A) and the crosslinking agent of the component (B). Parts by mass to 100 parts by mass, more preferably 5 parts by mass to 70 parts by mass.

又,在本實施形態之硬化膜形成組成物,(E)成分可為(E)成分之化合物的複數種之混合物。Moreover, in the cured film formation composition of this embodiment, (E)component may be a mixture of plural types of the compound of (E)component.

<溶劑> 本發明之硬化膜形成組成物作為主要,係以溶解在溶劑的溶液狀態使用。此時所使用之溶劑若可溶解(A)成分、(B)成分、(C)成分,及如有必要之(D)成分、(E)成分及/或後述之其他添加劑即可,其種類及構造等並非被特別限定者。<Solvent> The cured film-forming composition of the present invention is mainly used in a solution state dissolved in a solvent. The solvent to be used at this time may dissolve the (A) component, (B) component, (C) component, and if necessary (D) component, (E) component and/or other additives described later. The structure and the like are not particularly limited.

作為溶劑的具體例,例如可列舉甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、異丁醇、2-甲基-1-丁醇、n-戊醇、乙二醇單甲基醚、乙二醇單乙基醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇、二乙二醇單甲基醚、二乙二醇單乙基醚、丙二醇、丙二醇單甲基醚、丙二醇單甲基醚乙酸酯、丙二醇單乙基醚、丙二醇丙基醚、丙二醇丙基醚乙酸酯、甲苯、二甲苯、甲基乙基酮、異丁基甲基酮、環戊酮、環己酮、2-丁酮、3-甲基-2-戊酮、2-戊酮、2-庚酮、γ-丁內酯、2-羥基丙酸乙酯、2-羥基-2-甲基丙酸乙酯、乙氧基乙酸乙酯、羥基乙酸乙酯、2-羥基-3-甲基丁酸甲酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、丙酮酸甲酯、丙酮酸乙酯、乙酸乙酯、乙酸丁酯、乳酸乙酯、乳酸丁酯、環戊基甲基醚、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺及N-甲基-2-吡咯烷酮等。Specific examples of the solvent include methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, 2-methyl-1-butanol, n-pentanol, ethylene glycol mono Methyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether Ethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether, propylene glycol propyl ether, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone, Isobutyl methyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2-pentanone, 2-pentanone, 2-heptanone, gamma-butyrolactone, ethyl 2-hydroxypropionate ester, ethyl 2-hydroxy-2-methylpropionate, ethyl ethoxyacetate, ethyl hydroxyacetate, methyl 2-hydroxy-3-methylbutyrate, methyl 3-methoxypropionate, Ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl acetate, butyl acetate, ethyl lactate ester, butyl lactate, cyclopentyl methyl ether, N,N-dimethylformamide, N,N-dimethylacetamide and N-methyl-2-pyrrolidone, etc.

使用本發明之硬化膜形成組成物,於樹脂薄膜上形成硬化膜,製造配向材料時,甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、2-甲基-1-丁醇、2-庚酮、異丁基甲基酮、二乙二醇、丙二醇、丙二醇單甲基醚、環戊基甲基醚、丙二醇單甲基醚乙酸酯、乙酸乙酯、乙酸丁酯等,從樹脂薄膜為顯示耐性之溶劑的點來看較佳。When using the cured film forming composition of the present invention to form a cured film on a resin film and manufacture an alignment material, methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-methyl-1-butanol , 2-heptanone, isobutyl methyl ketone, diethylene glycol, propylene glycol, propylene glycol monomethyl ether, cyclopentyl methyl ether, propylene glycol monomethyl ether acetate, ethyl acetate, butyl acetate, etc., from The resin film is preferable in that it is a solvent exhibiting resistance.

此等之溶劑可1種單獨或以2種以上之組合使用。These solvents may be used alone or in combination of two or more.

<其他添加劑> 進而,本發明之硬化膜形成組成物,只要不損害本發明效果,如有必要可含有增感劑、界面活性劑、流變調整劑、顏料、染料、保存安定劑、消泡劑、抗氧化劑等。<Other additives> Furthermore, the cured film-forming composition of the present invention may contain a sensitizer, a surfactant, a rheology modifier, a pigment, a dye, a storage stabilizer, an antifoaming agent, and an antioxidant, if necessary, as long as the effect of the present invention is not impaired. Wait.

<硬化膜形成組成物的調製> 本發明之硬化膜形成組成物係含有(A)成分之聚合物、(B)成分之交聯劑及(C)成分之烷氧基矽烷,視期望可含有(D)成分之交聯觸媒及(E)成分之密著促進劑,而且,進而只要在不損害本發明效果,可含有其他添加劑之組成物。而且,通常該等作為溶解在溶劑之溶液的形態使用。<Preparation of cured film forming composition> The cured film-forming composition of the present invention contains the polymer of the component (A), the crosslinking agent of the component (B), and the alkoxysilane of the component (C), and may contain the crosslinking catalyst of the component (D) if desired. and the adhesion promoter of the component (E), and further, as long as the effect of the present invention is not impaired, a composition containing other additives may be included. In addition, these are usually used in the form of a solution dissolved in a solvent.

本發明之硬化膜形成組成物的較佳之例係如以下。 [1]:含有(A)成分、(B)成分及(C)成分之硬化膜形成組成物,其中,根據(A)成分100質量份,含有1質量份~500質量份之(B)成分,及根據(A)成分100質量份,含有0.001質量份~20質量份之(C)成分。 [2]:含有(A)成分、(B)成分及(C)成分、以及溶劑之硬化膜形成組成物,其中,根據(A)成分100質量份,含有1質量份~500質量份之(B)成分,根據(A)成分100質量份,含有0.001質量份~20質量份之(C)成分。 [3]:含有(A)成分、(B)成分、(C)成分、(D)成分、溶劑之硬化膜形成組成物,其中,根據(A)成分100質量份,含有1質量份~500質量份之(B)成分,相對於(A)成分之聚合物之100質量份,含有0.001質量份~20質量份之(C)成分,相對於(A)成分之聚合物及(B)成分之交聯劑的合計量之100質量份,含有0.01質量份~20質量份之(D)成分。 [4]:含有(A)成分、(B)成分、(C)成分、(D)成分、(E)成分、以及溶劑之硬化膜形成組成物,其中,根據(A)成分100質量份,含有1質量份~500質量份之(B)成分,相對於(A)成分之聚合物的100質量份,含有0.001質量份~20質量份之(C)成分,相對於(A)成分之聚合物及(B)成分之交聯劑的合計量之100質量份,含有0.01質量份~20質量份之(D)成分,相對於(A)成分之聚合物及(B)成分之交聯劑的合計量之100質量份,含有1質量份~100質量份之(E)成分。Preferable examples of the cured film-forming composition of the present invention are as follows. [1]: Cured film-forming composition containing (A) component, (B) component, and (C) component, containing 1 to 500 parts by mass of (B) component based on 100 parts by mass of (A) component , and based on 100 parts by mass of (A) component, 0.001 parts by mass to 20 parts by mass of (C) component are contained. [2]: The cured film-forming composition containing (A) component, (B) component, (C) component, and a solvent, in which 1 to 500 parts by mass of ( B) Component contains 0.001 to 20 parts by mass of (C) component based on 100 parts by mass of (A) component. [3]: The cured film-forming composition containing (A) component, (B) component, (C) component, (D) component, and a solvent, in which 1 to 500 parts by mass is contained based on 100 parts by mass of (A) component Component (B) in parts by mass, relative to 100 parts by mass of the polymer of component (A), contains 0.001 to 20 parts by mass of component (C) relative to the polymer of component (A) and component (B) 0.01 to 20 parts by mass of (D) component is contained in 100 parts by mass of the total amount of the crosslinking agent. [4]: Cured film-forming composition containing (A) component, (B) component, (C) component, (D) component, (E) component, and a solvent, wherein, based on 100 parts by mass of (A) component, Contains 1 to 500 parts by mass of component (B), relative to 100 parts by mass of the polymer of component (A), contains 0.001 to 20 parts by mass of component (C), relative to the polymerization of component (A) 100 parts by mass of the total amount of the crosslinking agent of the product and the component (B), containing 0.01 to 20 parts by mass of the component (D) relative to the polymer of the component (A) and the crosslinking agent of the component (B) The total amount of 100 parts by mass contains 1 to 100 parts by mass of the (E) component.

將本發明之硬化膜形成組成物作為溶液使用時之摻合比例、調製方法等詳述於以下。 在本發明之硬化膜形成組成物之固體成分的比例,只要各成分均一溶解在溶劑,雖並非被特別限定者,但為1質量%~60質量%,較佳為2質量%~50質量%,更佳為2質量%~20質量%。於此,所謂固體成分,係指從硬化膜形成組成物的全成分去除溶劑者。The mixing ratio, preparation method, etc. when the cured film forming composition of the present invention is used as a solution will be described in detail below. The ratio of the solid content of the cured film forming composition of the present invention is not particularly limited as long as each component is uniformly dissolved in the solvent, but is 1 to 60% by mass, preferably 2 to 50% by mass , more preferably 2% by mass to 20% by mass. Here, a solid content means what removed a solvent from all the components of a cured film formation composition.

本發明之硬化膜形成組成物的調製方法並未特別限定。作為調製法,例如可列舉於溶解在溶劑之(A)成分之溶液以指定的比例混合(B)成分、(C)成分,進而以指定的比例混合(D)成分、(E)成分等,而成為均一溶液之方法,或是在此調製法之適當的階段,如有必要進一步添加其他添加劑進行混合之方法。The preparation method of the cured film formation composition of this invention is not specifically limited. The preparation method includes, for example, mixing (B) component and (C) component in a solution of (A) component dissolved in a solvent at a predetermined ratio, and further mixing (D) component and (E) component at a predetermined ratio, etc., A method of forming a homogeneous solution, or a method of adding and mixing other additives if necessary at an appropriate stage of the preparation method.

在本發明之硬化膜形成組成物的調製,可直接使用藉由溶劑中之聚合反應所得之特定共聚物(聚合物)的溶液。此情況下,例如於(A)成分之溶液與前述相同放入(B)成分、(C)成分,進而放入(D)成分、(E)成分等而成為均一之溶液。此時,將濃度調整作為目的,可進一步追加投入溶劑。此時,於(A)成分之生成過程使用之溶劑、與使用在硬化膜形成組成物的濃度調整之溶劑可為相同,又亦可為相異。In the preparation of the cured film formation composition of this invention, the solution of the specific copolymer (polymer) obtained by the polymerization reaction in a solvent can be used as it is. In this case, for example, the solution of (A) component is put into (B) component, (C) component similarly to the above, and (D) component, (E) component etc. are further put into it, and it becomes a homogeneous solution. In this case, the solvent may be further added for the purpose of concentration adjustment. In this case, the solvent used in the production process of the component (A) and the solvent used for concentration adjustment of the cured film forming composition may be the same or different.

又,經調製之硬化膜形成組成物的溶液,較佳為使用孔徑超過0.2μm左右之過濾器等過濾後來使用。Moreover, it is preferable to filter and use the solution of the prepared cured film-forming composition using a filter or the like having a pore diameter exceeding about 0.2 μm.

<硬化膜、配向材料及相位差材料> 藉由將本發明之硬化膜形成組成物的溶液於基板(例如矽/二氧化矽被覆基板、氮化矽基板、金屬,例如被覆鋁、鉬、鉻等之基板、玻璃基板、石英基板、ITO基板等)之上,藉由棒塗、回轉塗佈、流動塗佈、輥塗佈、狹縫塗佈、狹縫接著回轉塗佈、噴墨塗佈、印刷等進行塗佈,形成塗膜,然後,以熱板或烤箱等進行加熱乾燥,可形成硬化膜。該硬化膜可適用直接作為配向材料。<Curing film, alignment material and retardation material> By applying the solution of the cured film-forming composition of the present invention to substrates (such as silicon/silicon dioxide coated substrates, silicon nitride substrates, metal substrates such as aluminum, molybdenum, chromium coated substrates, glass substrates, quartz substrates, ITO substrates, etc.), by bar coating, rotary coating, flow coating, roll coating, slit coating, slit followed by rotary coating, inkjet coating, printing, etc., to form a coating film, Then, it can be heated and dried with a hot plate, an oven, or the like to form a cured film. The cured film can be directly used as an alignment material.

作為加熱乾燥的條件,硬化膜(配向材料)的成分,於不溶出塗佈在其上之聚合性液晶溶液的程度,進行藉由交聯劑之交聯反應即可,採用例如從溫度60℃~200℃、時間0.4分鐘~60分鐘的範圍當中適當選擇之加熱溫度及加熱時間。加熱溫度及加熱時間較佳為70℃~160℃、0.5分鐘~10分鐘。As a condition for heating and drying, the components of the cured film (alignment material) may be subjected to a crosslinking reaction by a crosslinking agent to such an extent that the polymerizable liquid crystal solution applied thereon does not dissolve. Appropriately select heating temperature and heating time in the range of ~200°C and time from 0.4 minutes to 60 minutes. The heating temperature and heating time are preferably 70° C. to 160° C. for 0.5 minutes to 10 minutes.

使用本發明之硬化性組成物所形成之硬化膜(配向材料)的膜厚,例如為0.05μm~5μm,可考量使用之基板的段差或光學性、電氣性性質適當選擇。The thickness of the cured film (alignment material) formed using the curable composition of the present invention is, for example, 0.05 μm to 5 μm, and can be appropriately selected in consideration of the level difference, optical and electrical properties of the substrate to be used.

由於從本發明之硬化膜組成物所形成之配向材料具有耐溶劑性及耐熱性,故於此配向材料上,塗佈具有垂直配向性之聚合性液晶溶液等之相位差材料,可於配向材料上進行配向。而且,藉由直接將成為配向狀態之相位差材料硬化,作為具有光學各向異性之層,可形成相位差材料。Since the alignment material formed from the cured film composition of the present invention has solvent resistance and heat resistance, the alignment material can be coated with a retardation material such as a polymerizable liquid crystal solution having vertical alignment on the alignment material. alignment on. Furthermore, the retardation material can be formed as a layer having optical anisotropy by directly curing the retardation material in the aligned state.

又,使用如上述進行所形成之具有本發明之配向材料的2片基板,透過間隔,以使兩基板上之配向材料彼此面對面的方式貼合後,於該等之基板之間注入液晶,亦可成為液晶經配向之液晶顯示元件。 如此,本發明之硬化膜形成組成物,可適合使用在各種相位差材料或液晶顯示元件等之製造。 [實施例]Furthermore, using two substrates having the alignment material of the present invention formed as described above, and pasting the alignment materials on the two substrates so as to face each other through a gap, injecting liquid crystal between the substrates, also It can become a liquid crystal display element with aligned liquid crystal. Thus, the cured film formation composition of this invention can be used suitably for manufacture of various retardation materials, a liquid crystal display element, etc.. [Example]

以下,雖列舉本發明之實施例,具體說明本發明,但本發明並非被限定於此等來解釋者。 [於實施例使用之簡稱] 於以下之實施例使用之簡稱的意義係如以下。 <原料> GMA:縮水甘油基甲基丙烯酸酯 GLM:甘油單甲基丙烯酸酯 AIBN:α,α’-偶氮雙異丁腈 HEMA:2-羥基乙基甲基丙烯酸酯 <B成分> TMGU:1,3,4,6-肆(甲氧基甲基)甘脲(東京化成工業(股)製) HMM:下述之構造式表示之三聚氰胺交聯劑[CYMEL(CYMEL)(註冊商標)303(三井Cytec(股)製)]

Figure 02_image027
<C成分> SC-1:1-[3-(三乙氧基矽烷基)丙基]脲(東麗道康寧(股)製) SC-2:1-[3-(三甲氧基矽烷基)丙基]脲(東京化成工業(股)製) SC-3:3-異氰酸酯丙基三甲氧基矽烷(Momentive Performance Materials Japan合同公司製) SC-4:2-(3、4-環氧基環己基乙基)三甲氧基矽烷(信越矽利光製) SC-5:3-巰基丙基三甲氧基矽烷(信越矽利光製) SC-6:3-丙烯醯氧基丙基三甲氧基矽烷(信越矽利光製) <D成分> PPTS:p-甲苯磺酸・吡啶鹽 PTSA:p-甲苯磺酸・一水合物 <E成分> E-1:具有以下述之構造式表示之N-烷氧基甲基及丙烯醯基之化合物
Figure 02_image029
<溶劑> 實施例及比較例之各樹脂組成物含有溶劑,並作為其溶劑,係使用將丙二醇單甲基醚與乳酸乙酯以1對4之比混合之溶媒(PM/EL)。Hereinafter, although the Example of this invention is given and this invention is demonstrated concretely, this invention is not limited to these and it is not interpreted. [Abbreviations used in the examples] The meanings of the abbreviations used in the following examples are as follows. <Raw material> GMA: Glycidyl methacrylate GLM: Glycerol monomethacrylate AIBN: α,α'-azobisisobutyronitrile HEMA: 2-hydroxyethyl methacrylate <Component B> TMGU: 1,3,4,6-4(methoxymethyl)glycoluril (manufactured by Tokyo Chemical Industry Co., Ltd.) HMM: a melamine crosslinking agent represented by the following structural formula [CYMEL (CYMEL) (registered trademark) 303 (Mitsui Cytec Corporation)]
Figure 02_image027
<Component C> SC-1: 1-[3-(triethoxysilyl)propyl]urea (manufactured by Toray Dow Corning) SC-2: 1-[3-(trimethoxysilyl) Propyl]urea (manufactured by Tokyo Chemical Industry Co., Ltd.) SC-3: 3-isocyanatopropyltrimethoxysilane (manufactured by Momentive Performance Materials Japan Contract Co., Ltd.) SC-4: 2-(3,4-epoxy ring Hexylethyl)trimethoxysilane (manufactured by Shin-Etsu Silico) SC-5: 3-mercaptopropyltrimethoxysilane (manufactured by Shin-Etsu Silico) SC-6: 3-propenyloxypropyltrimethoxysilane ( Shin-Etsu Silicon Co., Ltd.) <Component D> PPTS: p-toluenesulfonic acid・pyridinium salt PTSA: p-toluenesulfonic acid・monohydrate <Component E> E-1: N-alkoxy represented by the following structural formula Compounds of methyl and acryloyl groups
Figure 02_image029
<Solvent> Each resin composition of Examples and Comparative Examples contained a solvent, and as the solvent, a solvent (PM/EL) in which propylene glycol monomethyl ether and ethyl lactate were mixed in a ratio of 1 to 4 was used.

<聚合物的分子量的測定> 在聚合例之丙烯酸共聚物的分子量,係使用Shodex公司(股)製常溫凝膠滲透層析(GPC)裝置(GPC-101)、Shodex公司製管柱(KD-803、KD-805),如以下般進行來測定。 尚,下述之數平均分子量(以下稱為Mn)及重量平均分子量(以下稱為Mw)係以聚苯乙烯換算值表示。 管柱溫度:40℃ 溶離液:四氫呋喃 流速:1.0mL/分鐘 檢量線作成用標準樣品:昭和電工公司製 標準聚苯乙烯(分子量約197,000、55,100、12,800、3,950、1,260、580)。<Measurement of molecular weight of polymer> In the molecular weight of the acrylic copolymer in the polymerization example, the room temperature gel permeation chromatography (GPC) apparatus (GPC-101) manufactured by Shodex Co. The measurement is carried out as follows. Incidentally, the following number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) are expressed in terms of polystyrene. Column temperature: 40℃ Eluent: tetrahydrofuran Flow rate: 1.0mL/min Standard sample for calibration curve preparation: Standard polystyrene manufactured by Showa Denko Co., Ltd. (molecular weight about 197,000, 55,100, 12,800, 3,950, 1,260, 580).

<A成分的合成> <聚合例1> 藉由將GMA 15.0g、作為聚合觸媒之AIBN 0.5g溶解在四氫呋喃46.4g,在加熱回流下使其反應20小時,而得到丙烯酸聚合物溶液。藉由將所得之丙烯酸共聚物溶液緩緩滴下於己烷500.0g,並使固體析出,進行過濾及減壓乾燥,而得到具有環氧基之丙烯酸聚合物(P1)。所得之丙烯酸聚合物之Mn為9,800,Mw為25,000。<Synthesis of Component A> <Polymerization example 1> An acrylic polymer solution was obtained by dissolving 15.0 g of GMA and 0.5 g of AIBN as a polymerization catalyst in 46.4 g of tetrahydrofuran, and making it react under heating under reflux for 20 hours. By slowly dropping the obtained acrylic copolymer solution into 500.0 g of hexane, the solid was precipitated, filtered and dried under reduced pressure to obtain an epoxy group-containing acrylic polymer (P1). The Mn of the obtained acrylic polymer was 9,800, and the Mw was 25,000.

<聚合例2> 藉由將GMA 16.0g、GLM 8.0g、作為聚合觸媒之AIBN 0.5g溶解在四氫呋喃80.0g,在加熱回流下使其反應20小時,而得到丙烯酸共聚物溶液。藉由將所得之丙烯酸共聚物溶液緩緩滴下於己烷500.0g,並使固體析出,進行過濾及減壓乾燥,而得到具有環氧基與羥基之丙烯酸共聚物(P2)。所得之丙烯酸聚合物之Mn為12,000,Mw為29,000。<Polymerization example 2> An acrylic copolymer solution was obtained by dissolving 16.0 g of GMA, 8.0 g of GLM, and 0.5 g of AIBN as a polymerization catalyst in 80.0 g of tetrahydrofuran, and making it react under heating under reflux for 20 hours. The acrylic copolymer solution (P2) having an epoxy group and a hydroxyl group was obtained by slowly dropping the obtained acrylic copolymer solution into 500.0 g of hexane, precipitation of a solid, filtration and drying under reduced pressure. The Mn of the obtained acrylic polymer was 12,000, and the Mw was 29,000.

<合成例1> 藉由將於聚合例1所得之具有環氧基之丙烯酸聚合物(P1)10.0g、4-甲氧基肉桂酸11.3g、作為反應觸媒之苄基三乙基氯化銨0.4g溶解在PM 50.8g,於120℃使其反應20小時。將此溶液緩緩滴下於二乙基醚500g,並使固體析出,進行過濾及減壓乾燥,而得到聚合物(PA-1)。測定所得之聚合物的環氧價,確認環氧基消失。<Synthesis example 1> By dissolving 10.0 g of the acrylic polymer (P1) having an epoxy group obtained in Polymerization Example 1, 11.3 g of 4-methoxycinnamic acid, and 0.4 g of benzyltriethylammonium chloride as a reaction catalyst in 50.8 g of PM was reacted at 120°C for 20 hours. This solution was gradually dripped into 500 g of diethyl ether, the solid was precipitated, filtered and dried under reduced pressure to obtain a polymer (PA-1). The epoxy value of the obtained polymer was measured, and it was confirmed that the epoxy group disappeared.

<合成例2> 藉由將於聚合例2所得之具有環氧基與羥基之丙烯酸聚合物(P2)5.0g、4-甲氧基肉桂酸 4.6g、作為反應觸媒之苄基三乙基氯化銨0.2g溶解在PM 22.8g,於120℃使其反應20小時。將此溶液緩緩滴下於二乙基醚500g,並使固體析出,進行過濾及減壓乾燥,而得到聚合物(PA-2)。測定所得之聚合物的環氧價,確認環氧基消失。<Synthesis example 2> 5.0 g of acrylic polymer (P2) having epoxy groups and hydroxyl groups obtained in Polymerization Example 2, 4.6 g of 4-methoxycinnamic acid, and 0.2 g of benzyltriethylammonium chloride as a reaction catalyst It was dissolved in 22.8 g of PM, and it was made to react at 120 degreeC for 20 hours. This solution was gradually dripped into 500 g of diethyl ether, a solid was deposited, filtered and dried under reduced pressure to obtain a polymer (PA-2). The epoxy value of the obtained polymer was measured, and it was confirmed that the epoxy group disappeared.

<C成分的合成> <聚合例3> 藉由將KBM-503(信越矽利光製)10.0g與HEMA5.2g、作為聚合起始劑之AIBN 0.7g溶解在PM 63.7g,於80℃使其反應20小時,而得到丙烯酸共聚物溶液(PC-1)。所得之丙烯酸聚合物之Mn為1,2100,Mw為2,9000。<Synthesis of C component> <Polymerization example 3> An acrylic copolymer solution ( PC-1). The Mn of the obtained acrylic polymer was 1,2100, and the Mw was 2,9000.

<聚合例4> 藉由將KBM-503 10.0g與HEMA 5.2g、AIBN 2.6g溶解在PM 72.0g,與聚合例3同樣進行反應,而得到Mn為1,4600,Mw為4,2300之高分子量共聚物(PC-2)。<Polymerization example 4> A high molecular weight copolymer (PC -2).

<聚合性液晶溶液的調製> 加入聚合性液晶LC242(BASF公司製)29.0g、作為聚合起始劑之Irgacure 907(BASF公司製)0.9g、作為整平劑之BYK-361N(BYK公司製)0.2g、作為溶媒之甲基異丁基酮,而得到固體成分濃度為30質量%之聚合性液晶溶液(RM-1)。<Preparation of polymerizable liquid crystal solution> 29.0 g of polymerizable liquid crystal LC242 (manufactured by BASF), 0.9 g of Irgacure 907 (manufactured by BASF) as a polymerization initiator, 0.2 g of BYK-361N (manufactured by BYK) as a leveling agent, and methyl as a solvent were added isobutyl ketone to obtain a polymerizable liquid crystal solution (RM-1) having a solid content concentration of 30% by mass.

<實施例、比較例> 在表1所示之組成,調製實施例及比較例之各硬化膜形成組成物。接著,使用各相位差材料形成組成物,形成硬化膜,針對所得之硬化膜個別進行配向性的評估。

Figure 02_image031
<Examples and comparative examples> In the composition shown in Table 1, each cured film formation composition of an Example and a comparative example was prepared. Next, a composition was formed using each retardation material, a cured film was formed, and the orientation of the obtained cured film was individually evaluated.
Figure 02_image031

[配向性的評估] 將實施例及比較例之各硬化膜形成組成物,於玻璃基板上使用旋塗機,以燒成後膜厚成為60nm的方式進行塗佈。分別於溫度100℃進行10分鐘,於熱板上進行加熱乾燥,於玻璃上分別形成硬化膜。於此各硬化膜將313nm的直線偏光以100mJ/cm2 的曝光量垂直照射,形成配向材料。於玻璃基板上之配向材料之上,將聚合性液晶溶液(RM-1)使用旋塗機,以成膜後之相位差值於550nm波長成為140nm左右的方式進行塗佈。將此塗膜以500mJ/cm2 進行曝光,製作相位差材料。將經製作之基板上之相位差材料以一對偏光板挾持,觀察在相位差材料之相位差特性的表現狀況,將相位差無缺陷表現者定為○,將相位差未表現者定為×,記載於「配向性」之欄。評估結果於後面集中示於表2。[Evaluation of Orientation] The cured film-forming compositions of Examples and Comparative Examples were coated on a glass substrate so that the film thickness after firing was 60 nm using a spin coater. The temperature was 100° C. for 10 minutes, respectively, and heat-drying was performed on a hot plate to form a cured film on the glass, respectively. Here, each cured film was vertically irradiated with a linearly polarized light of 313 nm at an exposure amount of 100 mJ/cm 2 to form an alignment material. On the alignment material on the glass substrate, the polymerizable liquid crystal solution (RM-1) was applied using a spin coater so that the retardation value after film formation was about 140 nm at a wavelength of 550 nm. This coating film was exposed to light at 500 mJ/cm 2 to produce a retardation material. Hold the phase difference material on the fabricated substrate with a pair of polarizers, and observe the performance of the phase difference characteristics on the phase difference material. The phase difference without defects is marked as ○, and the phase difference without phase difference is marked as × , recorded in the "Orientation" column. The evaluation results are collectively shown in Table 2 later.

[與基板的密著性的評估] 將實施例及比較例之各硬化膜形成組成物,於玻璃基板上使用旋塗機,以燒成後膜厚成為60nm的方式進行塗佈。分別於溫度100℃進行10分鐘,於熱板上進行加熱乾燥,於玻璃上分別形成硬化膜。於此各硬化膜將313nm的直線偏光以100mJ/cm2 的曝光量垂直照射,形成配向材料。對於配向材料使用切刀,將1cm寬度之缺口分別縱橫各放入11個,於配向材料上製作如成為100質量之格子狀般的溝。從於此上充分貼合接著膠帶,對於基板以45°之角度剝離時之殘留在玻璃基板上之配向材料之質量的比例,評估與配向材料所具有之玻璃基板的密著性。將幾乎殘留全部之配向材料者定為〇,將幾乎全部剝離者定為×,記載於「密著性」之欄。評估結果於後面集中示於表2。

Figure 02_image033
[Evaluation of Adhesion with Substrate] Each cured film-forming composition of Examples and Comparative Examples was applied on a glass substrate so that the film thickness after firing was 60 nm using a spin coater. The temperature was 100° C. for 10 minutes, respectively, and heat-drying was performed on a hot plate to form a cured film on the glass, respectively. Here, each cured film was vertically irradiated with a linearly polarized light of 313 nm at an exposure amount of 100 mJ/cm 2 to form an alignment material. Using a cutter for the alignment material, 11 notches with a width of 1 cm were placed vertically and horizontally, and grooves were formed in the alignment material in a lattice shape of 100 mass. Adhesion to the glass substrate possessed by the alignment material was evaluated with respect to the mass ratio of the alignment material remaining on the glass substrate when the substrate was peeled off at an angle of 45° from the sufficient adhesion of the adhesive tape. The case where almost all of the alignment material remained was designated as 0, and the case where almost all of the alignment material was peeled was designated as ×, and recorded in the column of "adhesion". The evaluation results are collectively shown in Table 2 later.
Figure 02_image033

如表2所示,於添加實施例1~12之具有矽氧烷基之矽烷偶合劑的配向材料,顯示良好之液晶配向性,並且顯示與玻璃基板之充分的密著性。As shown in Table 2, the alignment materials to which the silane coupling agents having siloxane groups of Examples 1 to 12 were added showed good liquid crystal alignment and sufficient adhesion to the glass substrate.

對此,於未添加反例1(比較例1)之矽烷偶合劑的組成物,除了顯示良好之液晶配向性外,並未顯示與玻璃之充分的密著性。又,於反例2(比較例2),雖將於實施例12顯示密著性之矽烷偶合劑的添加量與在實施例1~11之其他低分子矽烷偶合劑定為等量,但此組成物並未顯示與玻璃的密著性。此係因為於相對於組成物中之其他分子,為反應性低之矽烷偶合劑,有必要增多為了得到與玻璃之充分的密著性而添加之量。 [產業上之可利用性]In contrast, the composition to which the silane coupling agent of Counter Example 1 (Comparative Example 1) was not added did not exhibit sufficient adhesion to glass in addition to exhibiting favorable liquid crystal alignment. In addition, in Counter-Example 2 (Comparative Example 2), although the addition amount of the silane coupling agent showing adhesion in Example 12 was set to be the same amount as the other low-molecular-weight silane coupling agents in Examples 1 to 11, this composition The material did not show adhesion to glass. This is because it is a silane coupling agent with low reactivity with respect to other molecules in the composition, and it is necessary to increase the amount added in order to obtain sufficient adhesion with glass. [Industrial Availability]

藉由本發明之硬化膜形成組成物,作為液晶顯示元件之液晶配向膜,或作為形成用以形成於液晶顯示元件之設置於內部或外部之光學各向異性板的配向材料之材料非常有用,尤其是適合作為IPS-LCD或有機EL顯示器之抗反射膜使用之圓偏光板之用於相位差材料之材料。The cured film forming composition of the present invention is very useful as a liquid crystal alignment film for a liquid crystal display element, or as a material for forming an alignment material for an optically anisotropic plate disposed inside or outside the liquid crystal display element, especially It is a phase difference material suitable for circular polarizers used as anti-reflection films for IPS-LCD or organic EL displays.

Claims (10)

一種硬化膜形成組成物,其係含有: (A)具有光配向性基及熱交聯性基之聚合物、 (B)具有羥甲基或烷氧基甲基之交聯劑,及 (C)具有與烷氧基矽烷基部位不同之熱交聯性基之烷氧基矽烷。A hardened film-forming composition comprising: (A) a polymer having a photoalignment group and a thermally crosslinkable group, (B) a crosslinking agent having a methylol or alkoxymethyl group, and (C) The alkoxysilane which has a thermally crosslinkable group different from an alkoxysilyl group part. 如請求項1之硬化膜形成組成物,其係進一步含有(D)交聯觸媒。The cured film-forming composition according to claim 1, which further contains (D) a crosslinking catalyst. 如請求項1或2之硬化膜形成組成物,其係含有(E)具有一個以上之聚合性基、與選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所構成之群組中之至少一個基A,或與該基A進行反應之至少一個基的化合物。The cured film-forming composition according to claim 1 or 2, comprising (E) having one or more polymerizable groups and a group selected from the group consisting of a hydroxyl group, a carboxyl group, an amide group, an amino group, and an alkoxysilyl group A compound of at least one group A in the group, or at least one group reacted with the group A. 如請求項1至3中任一項之硬化膜形成組成物,其係根據(A)成分100質量份,含有1質量份~500質量份之(B)成分。The cured film forming composition according to any one of claims 1 to 3, which contains 1 to 500 parts by mass of component (B) based on 100 parts by mass of (A) component. 如請求項1至4中任一項之硬化膜形成組成物,其係相對於(A)成分之100質量份,含有0.001質量份~20質量份之(C)成分。The cured film forming composition according to any one of claims 1 to 4, which contains 0.001 parts by mass to 20 parts by mass of (C) component with respect to 100 parts by mass of (A) component. 如請求項2至5中任一項之硬化膜形成組成物,其係相對於(A)成分及(B)成分之交聯劑的合計量之100質量份,含有0.01質量份~20質量份之(D)成分。The cured film-forming composition according to any one of claims 2 to 5, containing 0.01 to 20 parts by mass relative to 100 parts by mass of the total amount of the crosslinking agent of the (A) component and (B) component The (D) component. 如請求項3至6中任一項之硬化膜形成組成物,其係相對於(A)成分及(B)成分之交聯劑的合計量之100質量份,含有1質量份~100質量份之(E)成分。The cured film-forming composition according to any one of claims 3 to 6, which contains 1 part by mass to 100 parts by mass relative to 100 parts by mass of the total amount of the crosslinking agent of (A) component and (B) component The (E) component. 一種硬化膜,其係使如請求項1至7之硬化膜形成組成物硬化而獲得。A cured film obtained by curing the cured film-forming composition as claimed in claims 1 to 7. 一種配向劑,其係使如請求項1至7之硬化膜形成組成物硬化而形成。An alignment agent formed by curing the cured film-forming composition according to claims 1 to 7. 一種相位差材料,其係具有使如請求項1至7之硬化膜形成組成物硬化所得之硬化膜。A retardation material having a cured film obtained by curing the cured film-forming composition of claims 1 to 7.
TW110104541A 2020-02-17 2021-02-05 Cured film-forming composition, alignment material, and phase difference material TW202146566A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020024098 2020-02-17
JP2020-024098 2020-02-17

Publications (1)

Publication Number Publication Date
TW202146566A true TW202146566A (en) 2021-12-16

Family

ID=77391119

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110104541A TW202146566A (en) 2020-02-17 2021-02-05 Cured film-forming composition, alignment material, and phase difference material

Country Status (3)

Country Link
JP (1) JPWO2021166701A1 (en)
TW (1) TW202146566A (en)
WO (1) WO2021166701A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107463066B (en) * 2011-10-11 2020-10-30 日产化学工业株式会社 Cured film-forming composition, alignment material, and phase difference material
JP6414053B2 (en) * 2013-04-16 2018-10-31 日産化学株式会社 Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
WO2015122335A1 (en) * 2014-02-13 2015-08-20 大日本印刷株式会社 Thermosetting composition having photoalignment properties, alignment layer, substrate with alignment layer, phase difference plate, and device

Also Published As

Publication number Publication date
WO2021166701A1 (en) 2021-08-26
JPWO2021166701A1 (en) 2021-08-26

Similar Documents

Publication Publication Date Title
JP5748061B2 (en) Thermosetting film forming composition having photo-alignment property
JP5459520B2 (en) Thermosetting film forming composition having photo-alignment property
US9823401B2 (en) Cured film formation composition, orientation material, and retardation material
JP5880865B2 (en) Thermosetting film forming composition having photo-alignment property
TW202024219A (en) Resin composition for forming retardation material, alignment material and retardation material
TWI644961B (en) Cured film forming composition, alignment material and retardation material
WO2018181364A1 (en) Cured film–forming composition, alignment material, and phase difference material
KR20200135968A (en) Cured film forming composition, alignment material, and retardation material
TWI822746B (en) Cured film forming composition, alignment material and retardation material
TWI653287B (en) Cured film forming composition, alignment material and retardation material
TW202146566A (en) Cured film-forming composition, alignment material, and phase difference material
TWI794261B (en) Cured film forming composition, alignment material and retardation material
JP7569016B2 (en) Cured film-forming composition, alignment material and retardation material
TWI850195B (en) Cured film formation composition, orientation material and retardation material